EurekaMag PDF full texts Chapter 8,428

Presisser, J.R.; Qaqish, B.F. 1996: Deletion diagnostics for generalised estimating equations. Biometrika 83(3): 551-562

Yang, Y.; Masker, W. 1996: Deletion during recombination in bacteriophage T7. Mutation Research 349(1): 21-32

Dubrana, K.; Le Mouël, A.; Amar, L. 1997: Deletion endpoint allele-specificity in the developmentally regulated elimination of an internal sequence (IES) in Paramecium. Nucleic Acids Research 25(12): 2448-2454

Mukaihara, T.; Enomoto, M. 1997: Deletion formation between the two Salmonella typhimurium flagellin genes encoded on the mini F plasmid: Escherichia coli ssb alleles enhance deletion rates and change hot-spot preference for deletion endpoints. Genetics 145(3): 563-572

Umehara, F.; Kiwaki, T.; Yoshikawa, H.; Nishimura, T.; Nakagawa, M.; Matsumoto, W.; Hashimoto, K.; Izumo, S.; Arimura, Y.; Arimura, K. 1995: Deletion in chromosome 17p11.2 including the peripheral myelin protein-22 (PMP-22) gene in hereditary neuropathy with liability to pressure palsies. Journal of the Neurological Sciences 133(1-2): 173-176

Devriendt, K.; Swillen, A.; Fryns, J.P. 1998: Deletion in chromosome region 22q11 in a child with CHARGE association. Clinical Genetics 53(5): 408-410

Gallego, M.I.; Lazo, P.A. 1995: Deletion in human chromosome region 12q13-15 by integration of human papillomavirus DNA in a cervical carcinoma cell line. Journal of Biological Chemistry 270(41): 24321-24326

Matsumoto, M.; Tange, Y.; Okada, T.; Inoue, Y.; Horiuchi, T.; Kobayashi, Y.; Fujita, S. 1996: Deletion in the 190 kDa antigen gene repeat region of Rickettsia rickettsii. Microbial Pathogenesis 20(1): 57-62

Muntoni, F.; Gobbi, P.; Sewry, C.; Sherratt, T.; Taylor, J.; Sandhu, S.K.; Abbs, S.; Roberts, R.; Hodgson, S.V.; Bobrow, M. 1994: Deletions in the 5' region of dystrophin and resulting phenotypes. Journal of Medical Genetics 31(11): 843-847

Verhalle, D.; Löfgren, A.; Nelis, E.; Dehaene, I.; Theys, P.; Lammens, M.; Dom, R.; Van Broeckhoven, C.; Robberecht, W. 1994: Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies. Annals of Neurology 35(6): 704-708

Mannermaa, A.; Pulkkinen, L.; Kajanoja, E.; Ryynänen, M.; Saarikoski, S. 1996: Deletion in the FMR1 gene in a fragile-X male. American Journal of Medical Genetics 64(2): 293-295

Suzuki, T.; Tomita, Y.; Nakano, K.; Shirasawa, H.; Simizu, B. 1995: Deletion in the L1 open reading frame of human papillomavirus type 6a genomes associated with recurrent laryngeal papilloma. Journal of Medical Virology 47(3): 191-197

Jäckel, M.; Witt, C.; Antonova, O.; Curdt, I.; Labeit, S.; Jockusch, H. 1997: Deletion in the Z-line region of the titin gene in a baby hamster kidney cell line, BHK-21-Bi. Febs Letters 408(1): 21-24

Fossarello, M.; Bertini, C.; Galantuomo, M.S.; Cao, A.; Serra, A.; Pirastu, M. 1996: Deletion in the peripherin/RDS gene in two unrelated Sardinian families with autosomal dominant butterfly-shaped macular dystrophy. Archives of Ophthalmology 114(4): 448-456

Björck, S.; Blohmé, G.; Sylvén, C.; Mulec, H. 1997: Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(Suppl): 67-70

Chen, T.; Sahin, A.; Aldaz, C.M. 1996: Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Research 56(24): 5605-5609

Takita, J.; Hayashi, Y.; Kohno, T.; Yamaguchi, N.; Hanada, R.; Yamamoto, K.; Yokota, J. 1997: Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Cancer Research 57(5): 907-912

Schnur, R.E.; Wick, P.A.; Sosnoski, D.N.; Bick, D.; Nussbaum, R.L. 1993: Deletion mapping and a highly reduced radiation hybrid in the Xp22.3-p22.2 region. Genomics 15(3): 500-506

Schröder, K.; Schuffenhauer, S.; Seidel, H.; Bartsch, O.; Blin, N.; Hinkel, G.K.; Schmitt, H. 1998: Deletion mapping by FISH with BACs in patients with partial monosomy 22q13. Human Genetics 102(5): 557-561

King, T.R.; Christianson, G.J.; Mitchell, M.J.; Bishop, C.E.; Scott, D.; Ehrmann, I.; Simpson, E.; Eicher, E.M.; Roopenian, D.C. 1994: Deletion mapping by immunoselection against the H-Y histocompatibility antigen further resolves the Sxra region of the mouse Y chromosome and reveals complexity of the Hya locus. Genomics 24(1): 159-168

Praml, C.; Finke, L.H.; Herfarth, C.; Schlag, P.; Schwab, M.; Amler, L. 1995: Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 11(7): 1357-1362

Wu, C.L.; Roz, L.; Sloan, P.; Read, A.P.; Holland, S.; Porter, S.; Scully, C.; Speight, P.M.; Thakker, N. 1997: Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes and Cancer 20(4): 347-353

Murty, V.V.; Reuter, V.E.; Bosl, G.J.; Chaganti, R.S. 1996: Deletion mapping identifies loss of heterozygosity at 5p15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors. Oncogene 12(12): 2719-2723

Takle, L.A.; Knowles, M.A. 1996: Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene 12(5): 1083-1087

Bieche, I.; Khodja, A.; Lidereau, R. 1998: Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma. Oncology Reports 5(1): 267-272

Cunningham, C.; Dunlop, M.G.; Wyllie, A.H.; Bird, C.C. 1993: Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene 8(5): 1391-1396

Cheng, N.C.; Van Roy, N.; Chan, A.; Beitsma, M.; Westerveld, A.; Speleman, F.; Versteeg, R. 1995: Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10(2): 291-297

Miura, K.; Okita, K.; Furukawa, Y.; Matsuno, S.; Nakamura, Y. 1995: Deletion mapping in squamous cell carcinomas of the esophagus defines a region containing a tumor suppressor gene within a 4-centimorgan interval of the distal long arm of chromosome 9. Cancer Research 55(9): 1828-1830

Guidal-Giroux, C.; Gérard, B.; Cavé, H.; Duval, M.; Rohrlich, P.; Elion, J.; Vilmer, E.; Grandchamp, B. 1996: Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9P21 in paediatric acute lymphoblastic leukaemias. British Journal of Haematology 92(2): 410-419

Schutte, M.E.; Ebeling, S.B.; Akkermans-Koolhaas, K.E.; Logtenberg, T. 1992: Deletion mapping of Ig VH gene segments expressed in human CD5 B cell lines. JH proximity is not the sole determinant of the restricted fetal VH gene repertoire. Journal of Immunology 149(12): 3953-3960

Lin, Y.J.; Lai, M.M. 1993: Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. Journal of Virology 67(10): 6110-6118

Herzog, C.R.; Wiseman, R.W.; You, M. 1994: Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Research 54(15): 4007-4010

Sonoda, Y.; Murakami, Y.; Tominaga, T.; Kayama, T.; Yoshimoto, T.; Sekiya, T. 1996: Deletion mapping of chromosome 10 in human glioma. Japanese Journal of Cancer Research: Gann 87(4): 363-367

Von Deimling, A.; Nagel, J.; Bender, B.; Lenartz, D.; Schramm, J.; Louis, D.N.; Wiestler, O.D. 1994: Deletion mapping of chromosome 19 in human gliomas. International Journal of Cancer 57(5): 676-680

Shin, E.; Fujita, S.; Takami, K.; Kurahashi, H.; Kurita, Y.; Kobayashi, T.; Mori, T.; Nishisho, I.; Takai, S. 1993: Deletion mapping of chromosome 1p and 22q in pheochromocytoma. Japanese Journal of Cancer Research: Gann 84(4): 402-408

Otsuka, T.; Kohno, T.; Mori, M.; Noguchi, M.; Hirohashi, S.; Yokota, J. 1996: Deletion mapping of chromosome 2 in human lung carcinoma. Genes Chromosomes and Cancer 16(2): 113-119

Kohno, T.; Takayama, H.; Hamaguchi, M.; Takano, H.; Yamaguchi, N.; Tsuda, H.; Hirohashi, S.; Vissing, H.; Shimizu, M.; Oshimura, M. 1993: Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 8(7): 1825-1832

Piao, Z.; Park, C.; Park, J.H.; Kim, H. 1998: Deletion mapping of chromosome 4q in hepatocellular carcinoma. International Journal of Cancer 79(4): 356-360

Knowles, M.A.; Shaw, M.E.; Proctor, A.J. 1993: Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 8(5): 1357-1364

Matsuyama, H.; Pan, Y.; Skoog, L.; Tribukait, B.; Naito, K.; Ekman, P.; Lichter, P.; Bergerheim, U.S. 1994: Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 9(10): 3071-3076

Shaw, M.E.; Knowles, M.A. 1995: Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes and Cancer 13(1): 1-8

Ohta, M.; Berd, D.; Shimizu, M.; Nagai, H.; Cotticelli M-G; Mastrangelo, M.; Shields, J.A.; Shields, C.L.; Croce, C.M.; Huebner, K. 1996: Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. International Journal of Cancer 65(6): 762-767

Chakrabarti, R.; Srivatsan, E.S.; Wood, T.F.; Eubanks, P.J.; Ebrahimi, S.A.; Gatti, R.A.; Passaro, E.; Sawicki, M.P. 1998: Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13. Genes Chromosomes and Cancer 22(2): 130-137

Affranchino, J.L.; González, S.A. 1997: Deletion mapping of functional domains in the rotavirus capsid protein VP6. Journal of General Virology 78: 1949-1955

Albarosa, R.; Colombo, B.M.; Roz, L.; Magnani, I.; Pollo, B.; Cirenei, N.; Giani, C.; Conti, A.M.; DiDonato, S.; Finocchiaro, G. 1996: Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. American Journal of Human Genetics 58(6): 1260-1267

Harwood, J.; Meuth, M. 1995: Deletion mapping of highly conserved transcribed sequence downstream from APRT locus. Somatic Cell and Molecular Genetics 21(3): 151-160

Salo, P.; Kääriäinen, H.; Page, D.C.; de la Chapelle, A. 1995: Deletion mapping of stature determinants on the long arm of the Y chromosome. Human Genetics 95(3): 283-286

Dopf, J.; Horiagon, T.M. 1996: Deletion mapping of the Aequorea victoria green fluorescent protein. Gene 173(1 Spec No): 39-44

Clark, P.A.; Lester, T.; Villard, L.; Fontes, M.; Kinnon, C. 1994: Deletion mapping of the DXS986, DXS995, and DXS1002 loci defines their order within Xq21. Journal of Medical Genetics 31(4): 344-345

Fults, D.; Pedone, C. 1993: Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes and Cancer 7(3): 173-177

Akagi, K.; Kurahashi, H.; Arita, N.; Hayakawa, T.; Monden, M.; Mori, T.; Takai, S.; Nishisho, I. 1995: Deletion mapping of the long arm of chromosome 22 in human meningiomas. International Journal of Cancer 60(2): 178-182

Hua, J.; Chen, X.; Patton, J.T. 1994: Deletion mapping of the rotavirus metalloprotein NS53 (NSP1): the conserved cysteine-rich region is essential for virus-specific RNA binding. Journal of Virology 68(6): 3990-4000

Boström, J.; Mühlbauer, A.; Reifenberger, G. 1997: Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas. Acta Neuropathologica 94(5): 479-485

Leonard, J.H.; Williams, G.; Walters, M.K.; Nancarrow, D.J.; Rabbitts, P.H. 1996: Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma. Genes Chromosomes and Cancer 15(2): 102-107

Lu, Y.Y.; Jhanwar, S.C.; Cheng, J.Q.; Testa, J.R. 1994: Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma. Genes Chromosomes and Cancer 9(1): 76-80

Ohata, H.; Emi, M.; Fujiwara, Y.; Higashino, K.; Nakagawa, K.; Futagami, R.; Tsuchiya, E.; Nakamura, Y. 1993: Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosomes and Cancer 7(2): 85-88

Perazzona, B.; Spudich, E.N.; Spudich, J.L. 1996: Deletion mapping of the sites on the Htri transducer for sensory rhodopsin i interaction. Journal of Bacteriology 178(22): 6475-6478

Bandera, C.A.; Takahashi, H.; Behbakht, K.; Liu, P.C.; LiVolsi, V.A.; Benjamin, I.; Morgan, M.A.; King, S.A.; Rubin, S.C.; Boyd, J. 1997: Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. Cancer Research 57(3): 513-515

Schuffenhauer, S.; Lichtner, P.; Peykar-Derakhshandeh, P.; Murken, J.; Haas, O., A.; Back, E.; Wolff, G.; Zabel, B.; Barisic, I.; Rauch, A.; Borochowitz, Z.; Dallapiccola, B.; Ross, M.; Meitinger, T. 1998: Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (GDS2). European Journal of Human Genetics 6(3): 213-225

Wu, C.L.; Sloan, P.; Read, A.P.; Harris, R.; Thakker, N. 1994: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Research 54(24): 6484-6488

Yaremko, M.L.; Wasylyshyn, M.L.; Paulus, K.L.; Michelassi, F.; Westbrook, C.A. 1994: Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas. Genes Chromosomes and Cancer 10(1): 1-6

Stehlin, C.; Dahm, A.; Kirschner, K. 1997: Deletion mutagenesis as a test of evolutionary relatedness of indoleglycerol phosphate synthase with other TIM barrel enzymes. Febs Letters 403(3): 268-272

Berens, C.; Pfleiderer, K.; Helbl, V.; Hillen, W. 1995: Deletion mutagenesis of Tn 10 Tet repressor--localization of regions important for dimerization and inducibility in vivo. Molecular Microbiology 18(3): 437-448

Sheffield, W.P.; Blajchman, M.A. 1995: Deletion mutagenesis of heparin cofactor II: Defining the minimum size of a thrombin inhibiting serpin. FEBS Letters 365(2-3): 189-192

Kunapuli, S.P.; DeLa Cadena, R.A.; Colman, R.W. 1993: Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains. Journal of Biological Chemistry 268(4): 2486-2492

Smulson, M.; Istock, N.; Ding, R.; Cherney, B. 1994: Deletion mutants of poly(ADP-ribose) polymerase support a model of cyclic association and dissociation of enzyme from DNA ends during DNA repair. Biochemistry 33(20): 6186-6191

Hsia, C.C.; Nakashima, Y.; Tabor, E. 1997: Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma. Biochemical and Biophysical Research Communications 241(3): 726-729

Barnard, E.C.; Brown, G.; Stow, N.D. 1997: Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins. Virology 237(1): 97-106

Daubner, S.C.; Piper, M.M. 1995: Deletion mutants of tyrosine hydroxylase identify a region critical for heparin binding. Protein Science: a Publication of the Protein Society 4(3): 538-541

Hermiston, T.W.; Tripp, R.A.; Sparer, T.; Gooding, L.R.; Wold, W.S. 1993: Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class i antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. Journal of Virology 67(9): 5289-5298

Yamada, M.; Yamada, M.; Watson, M.A.; Richelson, E. 1994: Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells. Molecular Pharmacology 46(3): 470-476

Hogue, B.G.; Nayak, D.P. 1994: Deletion mutation in the signal anchor domain activates cleavage of the influenza virus neuraminidase, a type II transmembrane protein. Journal of General Virology 75: 1015-1022

Kuhn, M.G.; Vermaas, W.F. 1993: Deletion mutations in a long hydrophilic loop in the photosystem II chlorophyll-binding protein CP43 in the cyanobacterium Synechocystis sp. PCC 6803. Plant Molecular Biology 23(1): 123-133

Fuscoe, J.C.; Zimmerman, L.J.; Harrington-Brock, K.; Moore, M.M. 1994: Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers. Carcinogenesis 15(7): 1463-1466

Xie, Q.W.; Tabor, C.W.; Tabor, H. 1993: Deletion mutations in the speED operon: Spermidine is not essential for the growth of Escherichia coli. Gene 126(1): 115-117

Jobert, S.; Bragado-Nilsson, E.; Samolyk, D.; Pedespan, J.M.; Marchal, C.; Reichert, S.; Mallet, J.; Pitiot, G. 1997: Deletion of 11 amino acids in tuberin associated with severe tuberous sclerosis phenotypes: evidence for a new essential domain in the first third of the protein. European Journal of Human Genetics: Ejhg 5(5): 280-287

Tonk, V.; Wyandt, H.E.; Michand, L.; Milunsky, A. 1992: Deletion of 15q12 in Angelman syndrome: Report of 3 new cases. Clinical Genetics 42(5): 229-233

Bardi, G.; Pandis, N.; Fenger, C.; Kronborg, O.; Bomme, L.; Heim, S. 1993: Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Research 53(8): 1895-1898

Perlman, E.J.; Valentine, M.B.; Griffin, C.A.; Look, A.T. 1996: Deletion of 1p36 in childhood endodermal sinus tumors by two-color fluorescence in situ hybridization: a pediatric oncology group study. Genes Chromosomes and Cancer 16(1): 15-20

Kasprzak, L.; Der Kaloustian, V.M.; Elliott, A.M.; Shevell, M.; Lejtenyi, C.; Eydoux, P. 1998: Deletion of 22q11 in two brothers with different phenotype. American Journal of Medical Genetics 75(3): 288-291

Prosser, S.; Sarra, R.; Swigart, P.; Ball, A.; Cockcroft, S. 1997: Deletion of 24 amino acids from the C-terminus of phosphatidylinositol transfer protein causes loss of phospholipase C-mediated inositol lipid signalling. Biochemical Journal 324: 19-23

Schwartz, M.L.; Bruce, J.; Shneidman, P.S.; Schlaepfer, W.W. 1995: Deletion of 3'-untranslated region alters the level of mRNA expression of a neurofilament light subunit transgene. Journal of Biological Chemistry 270(44): 26364-26369

Pfeiffer, R.A.; Lachmann, E.; Schreyer, W.; Volleth, M. 1993: Deletion of 9q22: a new observation suggesting a specific phenotype. Annales de Genetique 36(3): 167-170

Desbois-Mouthon, C.; Sert-Langeron, C.; Magre, J.; Oreal, E.; Blivet, M.J.; Flori, E.; Besmond, C.; Capeau, J.; Caron, M. 1996: Deletion of Asn281 in the alpha-subunit of the human insulin receptor causes constitutive activation of the receptor and insulin desensitization. Journal of Clinical Endocrinology and Metabolism 81(2): 719-727

Levy-Toledano, R.; Accili, D.; Taylor, S.I. 1993: Deletion of C-terminal 113 amino acids impairs processing and internalization of human insulin receptor: Comparison of receptors expressed in CHO and NIH-3T3 cells. Biochimica et Biophysica Acta 1220(1): 1-14

Yoshimoto, T.; Nagase, H.; Nakano, H.; Matsuzawa, A.; Nariuchi, H. 1996: Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region. Virology 223(2): 387-391

Willert, J.R.; Daneshvar, L.; Sheffield, V.C.; Cogen, P.H. 1995: Deletion of Chromosome Arm 17p DNA Sequences in Pediatric High-Grade and Juvenile Pilocytic Astrocytomas. Genes Chromosomes and Cancer 12(3): 165-172

Longnecker, R.; Miller, C.L.; Tomkinson, B.; Miao, X.Q.; Kieff, E. 1993: Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. Journal of Virology 67(8): 5068-5074

Kelemen, G.H.; Plaskitt, K.A.; Lewis, C.G.; Findlay, K.C.; Buttner, M.J. 1995: Deletion of DNA lying close to the glkA locus induces ectopic sporulation in Streptomyces coelicolor A3(2). Molecular Microbiology 17(2): 221-230

Hayashi, K.; Chen, W.G.; Chen, Y.Y.; Murakami, I.; Chen, H.L.; Ohara, N.; Nose, S.; Hamaya, K.; Matsui, S.; Bacchi, M.M.; Bacchi, C.E.; Chang, K.L.; Weiss, L.M. 1998: Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes. American Journal of Pathology 152(1): 191-198

Ivic, A.; Olden, D.; Wallington, E.J.; Lund, P.A. 1997: Deletion of Escherichia coli groEL is complemented by a Rhizobium leguminosarum groEL homologue at 37 degrees C but not at 43 degrees C. Gene 194(1): 1-8

Spanu, P. 1998: Deletion of HCf-a, a hydrophobin gene of Cladosporium fulvum, does not affect pathogenicity on tomato. Physiological and Molecular Plant Pathology 52(5): 323-334

Willman, C.L.; Sever, C.E.; Pallavicini, M.G.; Harada, H.; Tanaka, N.; Slovak, M.L.; Yamamoto, H.; Harada, K.; Meeker, T.C.; List, A.F. 1993: Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259(5097): 968-971

Lothe, R.A.; Andersen, S.N.; Hofstad, B.; Meling, G.I.; Peltomäki, P.; Heim, S.; Brøgger, A.; Vatn, M.; Rognum, T.O.; Børresen, A.L. 1995: Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes and Cancer 14(3): 182-188

Liu, R.; Zhu, J.; Jospe, N.; Furlanetto, R.W.; Bastian, W.; Livingston, J.N. 1995: Deletion of lysine 121 creates a temperature-sensitive alteration in insulin binding by the insulin receptor. Journal of Biological Chemistry 270(1): 476-482

Skerjanc, I.S.; Clarke, D.M.; Loo, T.W.; Maclennan, D.H. 1993: Deletion of NH2- and COOH-terminal sequences destroys function of the Ca2+ ATPase of rabbit fast-twitch skeletal muscle sarcoplasmic reticulum. Febs Letters 336(1): 168-170

Roesler, J.M.; Livingston, E.H.; Srivatsan, E.; Chang, P.; Wang, M.B. 1998: Deletion of P15 (MTS2) in head and neck squamous cell carcinomas. Journal of Surgical Research 77(1): 50-54

Caprara, M.G.; Waring, R.B. 1994: Deletion of P9 and stem-loop structures downstream from the catalytic core affects both 5' and 3' splicing activities in a group-I intron. Gene 143(1): 29-37

Arch, E.M.; Goodman, B.K.; Van Wesep, R.A.; Liaw, D.; Clarke, K.; Parsons, R.; McKusick, V.A.; Geraghty, M.T. 1997: Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. American Journal of Medical Genetics 71(4): 489-493

Yang, M.; Trumpower, B.L. 1994: Deletion of QCR6, the gene encoding subunit six of the mitochondrial cytochrome bc1 complex, blocks maturation of cytochrome c1, and causes temperature-sensitive petite growth in Saccharomyces cerevisiae. Journal of Biological Chemistry 269(2): 1270-1275

Bremner, R.; Du, D.C.; Connolly-Wilson, M.J.; Bridge, P.; Ahmad, K.F.; Mostachfi, H.; Rushlow, D.; Dunn, J.M.; Gallie, B.L. 1997: Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. American Journal of Human Genetics 61(3): 556-570

Ono, M.; Okada, H.; Bolland, S.; Yanagi, S.; Kurosaki, T.; Ravetch, J.V. 1997: Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90(2): 293-301

Yamashita, Y.; Miyazato, A.; Ohya, K.; Ikeda, U.; Shimada, K.; Miura, Y.; Ozawa, K.; Mano, H. 1996: Deletion of Src homology 3 domain results in constitutive activation of Tec protein-tyrosine kinase. Japanese Journal of Cancer Research: Gann 87(11): 1106-1110

Wang, Z.Q.; Orlikowsky, T.; Dudhane, A.; Mittler, R.; Blum, M.; Lacy, E.; Riethmüller, G.; Hoffmann, M.K. 1994: Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients. European Journal of Immunology 24(7): 1553-1557

Kaneko, Y.; Takeda, O.; Homma, C.; Maseki, N.; Miyoshi, H.; Tsunematsu, Y.; Williams, B.G.; Saunders, G.F.; Sakurai, M. 1993: Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan. Japanese Journal of Cancer Research: Gann 84(6): 616-624

Sauer, P.R.; Lottspeich, F.; Unger, E.; Mentele, R.; Michel, H. 1996: Deletion of a B800-850 light-harvesting complex in Rhodospirillum molischianum DSM119 leads to "revertants" expressing a B800-820 complex: insights into pigment binding. Biochemistry 35(20): 6500-6507

Bertolino, P.; Staschewski, M.; Trescol-Biémont, M.C.; Freisewinkel, I.M.; Schenck, K.; Chrétien, I.; Forquet, F.; Gerlier, D.; Rabourdin-Combe, C.; Koch, N. 1995: Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation. Journal of Immunology 154(11): 5620-5629

Gu, H.; Marth, J.D.; Orban, P.C.; Mossmann, H.; Rajewsky, K. 1994: Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265(5168): 103-106

Zákány, J.; Gérard, M.; Favier, B.; Duboule, D. 1997: Deletion of a HoxD enhancer induces transcriptional heterochrony leading to transposition of the sacrum. EMBO Journal 16(14): 4393-4402

Menasce, L.P.; Orphanos, V.; Santibanez-Koref, M.; Boyle, J.M.; Harrison, C.J. 1994: Deletion of a common region on the long arm of chromosome 6 in acute lymphoblastic leukaemia. Genes Chromosomes and Cancer 10(1): 26-29

Karkera, J.D.; Taymans, S.E.; Turner, G.; Yoshikawa, T.; Detera-Wadleigh, S.D.; Wadleigh, R.G. 1997: Deletion of a consensus oestrogen response element half-site in the glucocorticoid receptor of human multiple myeloma. British Journal of Haematology 99(2): 372-374

Szczesna-Skorupa, E.; Straub, P.; Kemper, B. 1993: Deletion of a conserved tetrapeptide, PPGP, in P450 2C2 results in loss of enzymatic activity without a change in its cellular location. Archives of Biochemistry and Biophysics 304(1): 170-175

Miller, G.P.; Benkovic, S.J. 1998: Deletion of a highly motional residue affects formation of the Michaelis complex for Escherichia coli dihydrofolate reductase. Biochemistry 37(18): 6327-6335

Sieron, A.L.; Fertala, A.; Ala-Kokko, L.; Prockop, D.J. 1993: Deletion of a large domain in recombinant human procollagen II does not alter the thermal stability of the triple helix. Journal of Biological Chemistry 268(28): 21232-21237

Uhlmann, E.J.; D'Sa-Eipper, C.; Subramanian, T.; Wagner, A.J.; Hay, N.; Chinnadurai, G. 1996: Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Research 56(11): 2506-2509

Volkman, B.F.; Wemmer, D.E. 1997: Deletion of a single amino acid changes the folding of an apamin hybrid sequence peptide to that of endothelin. Biopolymers 41(4): 451-460

Reijo, R.A.; Cho, D.S.; Huffaker, T.C. 1993: Deletion of a single-copy tRNA affects microtubule function in Saccharomyces cerevisiae. Genetics 135(4): 955-962

Jain, S.; Ohman, D.E. 1998: Deletion of algK in mucoid Pseudomonas aeruginosa blocks alginate polymer formation and results in uronic acid secretion. Journal of Bacteriology 180(3): 634-641

Grønskov, K.; Hjalgrim, H.; Bjerager, M.O.; Brøndum-Nielsen, K. 1997: Deletion of all CGG repeats plus flanking sequences in FMR1 does not abolish gene expression. American Journal of Human Genetics 61(4): 961-967

Jones, N.D.; Fluck, N.C.; Roelen, D.L.; Mellor, A.L.; Morris, P.J.; Wood, K.J. 1997: Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration. European Journal of Immunology 27(7): 1591-1600

Grimaldi, M.E.; Adamo, H.P.; Rega, A.F.; Penniston, J.T. 1996: Deletion of amino acid residues 18-75 inactivates the plasma membrane Ca2+ pump. Journal of Biological Chemistry 271(43): 26995-26997

Bhat, M.B.; Zhao, J.; Hayek, S.; Freeman, E.C.; Takeshima, H.; Ma, J. 1997: Deletion of amino acids 1641-2437 from the foot region of skeletal muscle ryanodine receptor alters the conduction properties of the Ca release channel. Biophysical Journal 73(3): 1320-1328

González-Barroso, M.M.; Fleury, C.; Levi-Meyrueis, C.; Zaragoza, P.; Bouillaud, F.; Rial, E. 1997: Deletion of amino acids 261-269 in the brown fat uncoupling protein converts the carrier into a pore. Biochemistry 36(36): 10930-10935

Roggenkamp, A.; Ruckdeschel, K.; Leitritz, L.; Schmitt, R.; Heesemann, J. 1996: Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils. Infection and Immunity 64(7): 2506-2514

Ono, Y.; Kinouchi, T.; Sorimachi, H.; Ishiura, S.; Suzuki, K. 1997: Deletion of an endosomal/lysosomal targeting signal promotes the secretion of Alzheimer's disease amyloid precursor protein (APP). Journal of Biochemistry 121(3): 585-590

Vanier, M.T.; Ferlinz, K.; Rousson, R.; Duthel, S.; Louisot, P.; Sandhoff, K.; Suzuki, K. 1993: Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa. Human Genetics 92(4): 325-330

Frank, P.G.; Bergeron, J.; Emmanuel, F.; Lavigne, J.P.; Sparks, D.L.; Denèfle, P.; Rassart, E.; Marcel, Y.L. 1997: Deletion of central alpha-helices in human apolipoprotein A-I: effect on phospholipid association. Biochemistry 36(7): 1798-1806

Nanashima, A.; Tagawa, Y.; Yasutake, T.; Fujise, N.; Kashima, K.; Nakagoe, T.; Ayabe, H. 1997: Deletion of chromosome 11 and development of colorectal carcinoma. Cancer Detection and Prevention 21(1): 7-11

Srivatsan, E.S.; Ying, K.L.; Seeger, R.C. 1993: Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosomes and Cancer 7(1): 32-37

Vandamme, B.; Lissens, W.; Amfo, K.; De Sutter, P.; Bourgain, C.; Vamos, E.; De Grève, J. 1992: Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor. Cancer Research 52(23): 6646-6652

Dahiya, R.; Mccarville, J.; Lee, C.; Hu, W.; Kaur, G.; Carroll, P.; Deng, G. 1997: Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. International Journal of Cancer 72(2): 283-288

Martinsson, T.; Sjöberg, R.M.; Hedborg, F.; Kogner, P. 1995: Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Research 55(23): 5681-5686

Brigaudeau, C.; Liozon, E.; Bernard, P.; Trimoreau, F.; Bordessoule, D.; Praloran, V. 1996: Deletion of chromosome 20q associated with hypereosinophilic syndrome. A report of two cases. Cancer Genetics and Cytogenetics 87(1): 82-84

White, N.J.; Nacheva, E.; Asimakopoulos, F.A.; Bloxham, D.; Paul, B.; Green, A.R. 1994: Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood 83(10): 2809-2816

Ahlbom, B.E.; Sidenvall, R.; Annerén, G. 1996: Deletion of chromosome 21 in a girl with congenital hypothyroidism and mild mental retardation. American Journal of Medical Genetics 64(3): 501-505

Craigen, W.J.; Lindsay, E.A.; Bricker, J.T.; Hawkins, E.P.; Baldini, A. 1997: Deletion of chromosome 22q11 and pseudohypoparathyroidism. American Journal of Medical Genetics 72(1): 63-65

Guo, Z.; Wilander, E.; Sällström, J.; Pontén, J. 1998: Deletion of chromosome 3p is an early event in malignant progression of cervical cancer. Anticancer Research 18(2a): 707-712

Mackie Ogilvie, C.; Rooney, S.C.; Hodgson, S.V.; Berry, A.C. 1998: Deletion of chromosome 3q proximal region gives rise to a variable phenotype. Clinical Genetics 53(3): 220-222

Koduru, P.R.; Zariwala, M.; Soni, M.; Gong, J.Z.; Xiong, Y.; Broome, J.D. 1995: Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Blood 86(8): 2900-2905

Schmetterer, G.; Alge, D.; Gregor, W. 1994: Deletion of cytochrome c oxidase genes from the cyanobacterium Synechocystis sp. PCC6803: Evidence for alternative respiratory pathways. Photosynthesis Research 42(1): 43-50

Markmann, J.F.; Odorico, J.S.; Bassiri, H.; Desai, N.; Kim, J.I.; Barker, C.F. 1993: Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells. Transplantation 55(4): 871

Koivisto, P.V.; Koivisto, U.M.; Kovanen, P.T.; Gylling, H.; Miettinen, T.A.; Kontula, K. 1993: Deletion of exon 15 of the LDL receptor gene is associated with a mild form of familial hypercholesterolemia. FH-Espoo. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 13(11): 1680-1688

Van der Kraan, M.; Kroos, M.A.; Joosse, M.; Bijvoet, A.G.; Verbeet, M.P.; Kleijer, W.J.; Reuser, A.J. 1994: Deletion of exon 18 is a frequent mutation in glycogen storage disease type II. Biochemical and Biophysical Research Communications 203(3): 1535-1541

Rolband, G.C.; Williams, J.F.; Webster, N.J.; Hsu, D.; Olefsky, J.M. 1993: Deletion of exon 21 of the insulin receptor eliminates tyrosine kinase activity but preserves mitogenic signaling. Biochemistry 32(49): 13545-13550

Wertheimer, E.; Litvin, Y.; Ebstein, R.P.; Bennet, E.R.; Barbetti, F.; Accili, D.; Taylor, S.I. 1994: Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance. Journal of Clinical Endocrinology and Metabolism 78(5): 1153-1158

Cigudosa, J.C.; Acosta Almeida, M.T.; Carrasco Juan, J.L.; Otero Gómez, A.; Hernández Nieto, L.; García Talavera, J.; García Miranda, J.L. 1996: Deletion of exon b3 of the BCR gene in CML: Easy breakpoint mapping by a two-round PCR. Cancer Genetics and Cytogenetics 91(1): 71-73

Kirkpatrick, D.T. 1997: Deletion of flanking ARS elements does not affect meiotic recombination at the HIS4 locus in yeast. Current Genetics 31(2): 106-111

Kuss, B.J.; Deeley, R.G.; Cole, S.P.; Willman, C.L.; Kopecky, K.J.; Wolman, S.R.; Eyre, H.J.; Lane, S.A.; Nancarrow, J.K.; Whitmore, S.A. 1994: Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: Prognostic implications. Lancet 343(8912): 1531-1534

Babic, N.; Klupp, B.; Brack, A.; Mettenleiter, T.C.; Ugolini, G.; Flamand, A. 1996: Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation. Virology 219(1): 279-284

Hoffmann, M.W.; Heath, W.R.; Ruschmeyer, D.; Miller, J.F. 1995: Deletion of high-avidity T cells by thymic epithelium. Proceedings of the National Academy of Sciences of the United States of America 92(21): 9851-9855

Uebele, V.N.; Yeola, S.W.; Snyders, D.J.; Tamkun, M.M. 1994: Deletion of highly conserved C-terminal sequences in the Kv1 K+ channel sub-family does not prevent expression of currents with wild-type characteristics. Febs Letters 340(1-2): 104-108

Neveux, N.; De Bandt, J.P.; Charrueau, C.; Savier, E.; Chaumeil, J.C.; Hannoun, L.; Giboudeau, J.; Cynober, L.A. 1997: Deletion of hydroxyethylstarch from University of Wisconsin solution induces cell shrinkage and proteolysis during and after cold storage of rat liver. Hepatology 25(3): 678-682

Zhang, W.Y.; Dai, R.M.; Wu, H.C. 1992: Deletion of internal twenty-one amino acid residues of Escherichia coli prolipoprotein does not affect formation of the murein-bound lipoprotein. FEBS (Federation of European Biochemical Societies) Letters 311(3): 311-314

Kato, T.; Takahashi, Y. 1996: Deletion of leukocyte mitochondrial DNA in bipolar disorder. Journal of Affective Disorders 37(2-3): 67-73

Wunderle, V.M.; Critcher, R.; Hastie, N.; Goodfellow, P.N.; Schedl, A. 1998: Deletion of long-range regulatory elements upstream of SOX9 causes campomelic dysplasia. Proceedings of the National Academy of Sciences of the United States of America 95(18): 10649-10654

Rötig, A.; Cormier, V.; Chatelain, P.; Francois, R.; Saudubray, J.M.; Rustin, P.; Munnich, A. 1993: Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). Journal of Clinical Investigation 91(3): 1095-1098

Rötig, A.; Goutières, F.; Niaudet, P.; Rustin, P.; Chretien, D.; Guest, G.; Mikol, J.; Gubler, M.C.; Munnich, A. 1995: Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. Journal of Pediatrics 126(4): 597-601

Chiu, Y.H.; Xiang, X.; Dawe, A.L.; Morris, N.R. 1997: Deletion of nudC, a nuclear migration gene of Aspergillus nidulans, causes morphological and cell wall abnormalities and is lethal. Molecular Biology of the Cell 8(9): 1735-1749

Jen, J.; Harper, J.W.; Bigner, S.H.; Bigner, D.D.; Papadopoulos, N.; Markowitz, S.; Willson, J.K.; Kinzler, K.W.; Vogelstein, B. 1994: Deletion of p16 and p15 genes in brain tumors. Cancer Research 54(24): 6353-6358

Yi, X.; Freund, R. 1998: Deletion of proline-rich domain in polyomavirus T antigens results in virus partially defective in transformation and tumorigenesis. Virology 248(2): 420-431

Drazek, E.S.; Houng, H.S.; Crawford, R.M.; Hadfield, T.L.; Hoover, D.L.; Warren, R.L. 1995: Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages. Infection and Immunity 63(9): 3297-3301

Crawford, R.M.; Van De Verg, L.; Yuan, L.; Hadfield, T.L.; Warren, R.L.; Drazek, E.S.; Houng, H.H.; Hammack, C.; Sasala, K.; Polsinelli, T.; Thompson, J.; Hoover, D.L. 1996: Deletion of purE attenuates Brucella melitensis infection in mice. Infection and Immunity 64(6): 2188-2192

Gravekamp, C.; Rosner, B.; Madoff, L.C. 1998: Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice. Infection and Immunity 66(9): 4347-4354

Sung, C.K.; Wong, K.Y.; Yip, C.C.; Hawley, D.M.; Goldfine, I.D. 1994: Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation. Molecular Endocrinology 8(3): 315-324

Dodd, I.; Browne, M.J.; Chapman, C.G.; Cronk, D.; Hastwell, C.; Wilson, S.; Robinson, J.H. 1993: Deletion of residues K296-G302 from the slowly-cleared tissue-type plasminogen activator t-PA del (G) leads to partial loss of plasminogen activating activity. Biologicals: Journal of the International Association of Biological Standardization 21(3): 269-274

Maeda, T.; Webb, D.R.; Chen, J.; Kobata, T.; Hirose, S.; Shirai, T.; Takabayashi, K.; Nishioka, K.; Sumida, T. 1998: Deletion of signaling molecule genes resembling the cytoplasmic domain of Igbeta in autoimmune-prone mice. International Immunology 10(6): 815-821

Oka, M.; Ogita, K.; Ando, H.; Horikawa, T.; Hayashibe, K.; Saito, N.; Kikkawa, U.; Ichihashi, M. 1996: Deletion of specific protein kinase C subspecies in human melanoma cells. Journal of Cellular Physiology 167(3): 406-412

Sun, J.; McCaughan, G.W.; Gallagher, N.D.; Sheil, A.G.; Bishop, G.A. 1995: Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 60(3): 233-236

Graham, L.A.; Phillips, J.D.; Trumpower, B.L. 1992: Deletion of subunit 9 of the Saccharomyces cerevisiae cytochrome bc1 complex specifically impairs electron transfer at the ubiquinol oxidase site (center P) in the bc1 complex. Febs Letters 313(3): 251-254

Komori, T.; Sugiyama, H. 1995: Deletion of the 3' splice site of the leader-variable region intron of immunoglobulin heavy chain genes induces a direct splicing of leader to constant region, resulting in the production of truncated mu-chains. European Journal of Immunogenetics: Official Journal of the British Society for Histocompatibility and Immunogenetics 22(3): 241-247

Maru, Y.; Witte, O.N.; Shibuya, M. 1996: Deletion of the ABL SH3 domain reactivates de-oligomerized BCR-ABL for growth factor independence. Febs Letters 379(3): 244-246

Nwaka, S.; Mechler, B.; Holzer, H. 1996: Deletion of the ATH1 gene in Saccharomyces cerevisiae prevents growth on trehalose. Febs Letters 386(2-3): 235-238

Jin, S.; Levin, P.A.; Matsuno, K.; Grossman, A.D.; Sonenshein, A.L. 1997: Deletion of the Bacillus subtilis isocitrate dehydrogenase gene causes a block at stage i of sporulation. Journal of Bacteriology 179(15): 4725-4732

Jalanko, A.; Manninen, T.; Peltonen, L. 1995: Deletion of the C-terminal end of aspartylglucosaminidase resulting in a lysosomal accumulation disease: evidence for a unique genomic rearrangement. Human Molecular Genetics 4(3): 435-441

Geber, A.; Hitchcock, C.A.; Swartz, J.E.; Pullen, F.S.; Marsden, K.E.; Kwon-Chung, K.J.; Bennett, J.E. 1995: Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrobial Agents and ChemoTherapy 39(12): 2708-2717

Slagle, B.L.; Zhou, Y.Z.; Birchmeier, W.; Scorsone, K.A. 1993: Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology 18(4): 757-762

Weiden, M.D.; Ginsberg, H.S. 1994: Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proceedings of the National Academy of Sciences of the United States of America 91(1): 153-157

Bottaro, A.; Young, F.; Chen, J.; Serwe, M.; Sablitzky, F.; Alt, F.W. 1998: Deletion of the IgH intronic enhancer and associated matrix-attachment regions decreases, but does not abolish, class switching at the mu locus. International Immunology 10(6): 799-806

Spritz, R.A.; Droetto, S.; Fukushima, Y. 1992: Deletion of the KIT and PDGFRA genes in a patient with piebaldism. American Journal of Medical Genetics 44(4): 492-495

Smart, S.L.; Lopantsev, V.; Zhang, C.L.; Robbins, C.A.; Wang, H.; Chiu, S.Y.; Schwartzkroin, P.A.; Messing, A.; Tempel, B.L. 1998: Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 20(4): 809-819

Piao, Z.; Choi, Y.; Park, C.; Lee, W.J.; Park, J.H.; Kim, H. 1997: Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma. Cancer Letters 120(1): 39-43,. 25

Lamb, H.K.; Dodds, A.L.; Swatman, D.R.; Cairns, E.; Hawkins, A.R. 1997: Deletion of the N-terminal region of the AREA protein is correlated with a derepressed phenotype with respect to nitrogen metabolite repression. Journal of Bacteriology 179(21): 6649-6656

Weber, M.; Uguccioni, M.; Baggiolini, M.; Clark-Lewis, I.; Dahinden, C.A. 1996: Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. Journal of Experimental Medicine 183(2): 681-685

Ajlani, G.; Vernotte, C. 1998: Deletion of the PB-loop in the L(CM) subunit does not affect phycobilisome assembly or energy transfer functions in the cyanobacterium Synechocystis sp. PCC6714. European Journal of Biochemistry 257(1): 154-159

Nixon, P.J.; Komenda, J.; Barber, J.; Deak, Z.; Vass, I.; Diner, B.A. 1995: Deletion of the PEST-like region of photosystem two modifies the QB-binding pocket but does not prevent rapid turnover of D1. Journal of Biological Chemistry 270(25): 14919-14927

Rasty, S.; Poliani, P.L.; Fink, D.J.; Glorioso, J.C. 1997: Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. Journal of Neurovirology 3(4): 247-264

Okada, M.; Howell, B.W.; Broome, M.A.; Cooper, J.A. 1993: Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine. Journal of Biological Chemistry 268(24): 18070-18075

Pearson, G.D.; Merrill, G.F. 1998: Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression. Journal of Biological Chemistry 273(10): 5431-5434

Roush, A.A.; Suarez, M.; Friedberg, E.C.; Radman, M.; Siede, W. 1998: Deletion of the Saccharomyces cerevisiae gene RAD30 encoding an Escherichia coli DinB homolog confers UV radiation sensitivity and altered mutability. Molecular and General Genetics: Mgg 257(6): 686-692

Dzelzkalns, V.A.; Obinger, C.; Regelsberger, G.; Niederhauser, H.; Kamensek, M.; Peschek, G.A.; Bogorad, L. 1994: Deletion of the structural gene for the NADH-dehydrogenase subunit 4 of Synechocystis 6803 alters respiratory properties. Plant Physiology 106(4): 1435-1442

Stephenson, J.; Czepulkowski, B.; Hirst, W.; Mufti, G.J. 1996: Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). Leukemia Research 20(3): 235-241

Reincke, M.; Mora, P.; Beuschlein, F.; Arlt, W.; Chrousos, G.P.; Allolio, B. 1997: Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis. Journal of Clinical Endocrinology and Metabolism 82(9): 3054-3058

Kullik, I.; Giachino, P.; Fuchs, T. 1998: Deletion of the alternative sigma factor sigmaB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. Journal of Bacteriology 180(18): 4814-4820

Zoidl, G.; Brockmann, D.; Esche, H. 1993: Deletion of the beta-turn/alpha-helix motif at the exon 2/3 boundary of human c-Myc leads to the loss of its immortalizing function. Gene 131(2): 269-274

Lin, X.H.; Ali, M.A.; Openshaw, H.; Cantin, E.M. 1996: Deletion of the carboxy-terminus of herpes simplex virus type 1 (HSV-1) glycoprotein B does not affect oligomerization, heparin-binding activity, or its ability to protect against HSV challenge. Archives of Virology 141(6): 1153-1165

Li, N.; Mattoo, A.K. 1994: Deletion of the carboxyl-terminal region of 1-aminocyclopropane-1-carboxylic acid synthase, a key protein in the biosynthesis of ethylene, results in catalytically hyperactive, monomeric enzyme. Journal of Biological Chemistry 269(9): 6908-6917

Moriggl, R.; Gouilleux-Gruart, V.; Jähne, R.; Berchtold, S.; Gartmann, C.; Liu, X.; Hennighausen, L.; Sotiropoulos, A.; Groner, B.; Gouilleux, F. 1996: Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Molecular and Cellular Biology 16(10): 5691-5700

Shelley, RM. 1991: Deletion of the centipede Theatops spinicaudus (Wood) from the Hawaiian fauna (Scolopendromorpha: Cryptopidae). Bishop Museum Occasional Papers 31: 182-184

Brady, L.J.; Cvitkovitch, D.G.; Geric, C.M.; Addison, M.N.; Joyce, J.C.; Crowley, P.J.; Bleiweis, A.S. 1998: Deletion of the central proline-rich repeat domain results in altered antigenicity and lack of surface expression of the Streptococcus mutans P1 adhesin molecule. Infection and Immunity 66(9): 4274-4282

Shi, J.; Zhu, H.; Arvidson, D.N.; Cregg, J.M.; Woldegiorgis, G. 1998: Deletion of the conserved first 18 N-terminal amino acid residues in rat liver carnitine palmitoyltransferase i abolishes malonyl-CoA sensitivity and binding. Biochemistry 37(31): 11033-11038

Sun, F.; Knebelmann, B.; Pueyo, M.E.; Zouali, H.; Lesage, S.; Vaxillaire, M.; Passa, P.; Cohen, D.; Velho, G.; Antignac, C. 1993: Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young. Journal of Clinical Investigation 92(3): 1174-1180

Wu, B.L.; Schneider, G.H.; Korf, B.R. 1997: Deletion of the entire NF1 gene causing distinct manifestations in a family. American Journal of Medical Genetics 69(1): 98-101

Engman, H.W.; Kreuzer, K.N. 1993: Deletion of the essential gene 24 from the bacteriophage T4 genome. Gene 123(1): 69-74

Yun, C.H.; Barquera, B.; Iba, K.; Takamiya, K.I.; Shapleigh, J.; Crofts, A.R.; Gennis, R.B. 1994: Deletion of the gene encoding cytochrome b-562 from Rhodobacter sphaeroides. Fems Microbiology Letters 120(1-2): 105-110

Timblin, B.K.; Tatchell, K.; Bergman, L.W. 1996: Deletion of the gene encoding the cyclin-dependent protein kinase Pho85 alters glycogen metabolism in Saccharomyces cerevisiae. Genetics 143(1): 57-66

Brabetz, W.; Müller-Loennies, S.; Holst, O.; Brade, H. 1997: Deletion of the heptosyltransferase genes rfaC and rfaF in Escherichia coli K-12 results in an Re-type lipopolysaccharide with a high degree of 2-aminoethanol phosphate substitution. European Journal of Biochemistry 247(2): 716-724

Jenkins, F.J.; Donoghue, A.M.; Martin, J.R. 1996: Deletion of the herpes simplex virus 1 internal repeat sequences affects pathogenicity in the mouse. Frontiers in Bioscience (online) 1(CITED DEC 9, ): A59-68

Takeda, S.; Zou, Y.R.; Bluethmann, H.; Kitamura, D.; Muller, U.; Rajewsky, K. 1993: Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearrangement in trans. EMBO Journal 12(6): 2329-2336

Rolband, G.C.; Williams, J.F.; Webster, N.J.; Olefsky, J.M. 1993: Deletion of the insulin receptor beta-subunit acidic domain results in enhanced metabolic signaling. Endocrinology 133(3): 1437-1443

Torello, A.T.; Overholtzer, M.H.; Cameron, V.L.; Bonnefoy, N.; Fox, T.D. 1997: Deletion of the leader peptide of the mitochondrially encoded precursor of Saccharomyces cerevisiae cytochrome c oxidase subunit II. Genetics 145(4): 903-910

Matano, S.; Nakamura, S.; Kobayashi, K.; Yoshida, T.; Matsuda, T.; Sugimoto, T. 1997: Deletion of the long arm of chromosome 20 in a patient with chronic neutrophilic leukemia: Cytogenetic findings in chronic neutrophilic leukemia. American Journal of Hematology 54(1): 72-75

Cotter, P.D.; Tumewu, P.; Browett, P.J. 1993: Deletion of the long arm of chromosome 20 in a patient with small cell lymphocytic lymphoma. Cancer Genetics and Cytogenetics 70(2): 142-143

Evers, L.J.; Schrander-Stumpel, C.T.; Engelen, J.J.; Hoorntje, T.M.; Pulles-Heintzberger, C.F.; Schrander, J.J.; Albrechts, J.C.; Peters, J.; Fryns, J.P. 1996: Deletion of the long arm of chromosome 6: Two new patients and literature review. Clinical Genetics 50(3): 138-144

Davidovitz, Y.; Zimlichman, R.; Rosner, E.; Berkowic, M.; Ballin, A.; Meytes, D. 1997: Deletion of the long arm of chromosome 7 in myelomonocytic leukemia with bone marrow eosinophilia. Cancer Genetics and Cytogenetics 97(2): 122-124

Coppin, E.; Arnaise, S.; Contamine, V.; Picard, M. 1993: Deletion of the mating-type sequences in Podospora anserina abolishes mating without affecting vegetative functions and sexual differentiation. Molecular and general genetics: MGG 241(3-4): 409-414

Niaudet, P.; Heidet, L.; Munnich, A.; Schmitz, J.; Bouissou, F.; Gubler, M.C.; Rötig, A. 1994: Deletion of the mitochondrial DNA in a case of de Toni-Debré-Fanconi syndrome and Pearson syndrome. Pediatric Nephrology 8(2): 164-168

Zhou, Y.; He, L.; Baumann, G.; Kopchick, J.J. 1997: Deletion of the mouse GH-binding protein (mGHBP) mRNA polyadenylation and splicing sites does not abolish production of mGHBP. Journal of Molecular Endocrinology 19(1): 1-13

Bouvier, G.; Watrin, F.; Naspetti, M.; Verthuy, C.; Naquet, P.; Ferrier, P. 1996: Deletion of the mouse T-cell receptor beta gene enhancer blocks alphabeta T-cell development. Proceedings of the National Academy of Sciences of the United States of America 93(15): 7877-7881

Pfleiderer, M.; Falkner, F.G.; Dorner, F. 1996: Deletion of the myristylation signal allows high-level production of the hepatitis B virus large surface glycoprotein preS1 with vaccinia virus recombinants. Gene 176(1-2): 131-137

Kaplan, R.S.; Mayor, J.A.; Kakhniashvili, D.; Gremse, D.A.; Wood, D.O.; Nelson, D.R. 1996: Deletion of the nuclear gene encoding the mitochondrial citrate transport protein from Saccharomyces cerevisiae. Biochemical and Biophysical Research Communications 226(3): 657-662

Orlow, I.; Lacombe, L.; Hannon, G.J.; Serrano, M.; Pellicer, I.; Dalbagni, G.; Reuter, V.E.; Zhang, Z.F.; Beach, D.; Cordon-Cardo, C. 1995: Deletion of the p16 and p15 genes in human bladder tumors. Journal of the National Cancer Institute 87(20): 1524-1529

Silber, K.R.; Sauer, R.T. 1994: Deletion of the prc (tsp) gene provides evidence for additional tail-specific proteolytic activity in Escherichia coli K-12. Molecular and General Genetics: Mgg 242(2): 237-240

Pillutla, R.C.; Ahnn, J.; Inouye, M. 1996: Deletion of the putative effector region of Era, an essential GTP-binding protein in Escherichia coli, causes a dominant-negative phenotype. Fems Microbiology Letters 143(1): 47-55

Voordouw, J.K.; Voordouw, G. 1998: Deletion of the rbo gene increases the oxygen sensitivity of the sulfate-reducing bacterium Desulfovibrio vulgaris Hildenborough. Applied and Environmental Microbiology 64(8): 2882-2887

Moczko, M.; Ehmann, B.; Gärtner, F.; Hönlinger, A.; Schäfer, E.; Pfanner, N. 1994: Deletion of the receptor MOM19 strongly impairs import of cleavable preproteins into Saccharomyces cerevisiae mitochondria. Journal of Biological Chemistry 269(12): 9045-9051

Dao, D.D.; Sawyer, J.R.; Epstein, J.; Hoover, R.G.; Barlogie, B.; Tricot, G. 1994: Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 8(8): 1280-1284

Pandis, N.; Bardi, G.; Mitelman, F.; Heim, S. 1997: Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosomes and Cancer 18(4): 241-245

Massa, G.; Vanderschueren-Lodeweyckx, M.; Fryns, J.P. 1992: Deletion of the short arm of the X chromosome: A hereditary form of Turner syndrome. European Journal of Pediatrics 151(12): 893-894

Ho, N.K.; Ng, I.S. 1993: Deletion of the terminal segment of the long arm of chromosome 4 with aortic stenosis. Journal of Paediatrics and Child Health 29(6): 473-475

Ball, S.G.; Ikeda, M.; Chin, W.W. 1997: Deletion of the thyroid hormone beta1 receptor increases basal and triiodothyronine-induced growth hormone messenger ribonucleic acid in GH3 cells. Endocrinology 138(8): 3125-3132

Wolffe, E.J.; Isaacs, S.N.; Moss, B. 1993: Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. Journal of Virology 67(8): 4732-4741

Heineman, T.C.; Cohen, J.I. 1994: Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. Journal of Virology 68(5): 3317-3323

Foury, F.; Cazzalini, O. 1997: Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Letters 411(2-3): 373-377

Tamura, K.; Zhang, X.; Murakami, Y.; Hirohashi, S.; Xu, H.J.; Hu, S.X.; Benedict, W.F.; Sekiya, T. 1997: Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. International Journal of Cancer 74(1): 45-49

Krishnamurthy, S.; Chatterjee, U.; Gupta, V.; Prasad, R.; Das, P.; Snehlata, P.; Hasnain, S.E.; Prasad, R. 1998: Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system. Yeast 14(6): 535-550

Alimsardjono, H.; Mukono, I.S.; Dachlan, Y.P.; Matsuo, M. 1997: Deletion of twenty seven nucleotides within exon 11 of the band 3 gene identified in ovalocytosis in Lombok Island, Indonesia. Japanese Journal of Human Genetics 42(1): 233-236

Wu, S.C.; Ham, K.S.; Darvill, A.G.; Albersheim, P. 1997: Deletion of two Endo-beta-1,4-xylanase genes reveals additional isozymes secreted by the rice blast fungus. Molecular Plant-Microbe Interactions 10(6): 700-708

Keon, R.G.; Fu, R.; Voordouw, G. 1997: Deletion of two downstream genes alters expression of the hmc operon of Desulfovibrio vulgaris subsp. vulgaris Hildenborough. Archives of Microbiology 167(6): 376-383

Bakker, H.; Van Tetering, A.; Agterberg, M.; Smit, A.B.; Van Den Eijnden, D.H.; Van Die, I. 1997: Deletion of two exons from the Lymnaea stagnalis beta-1 fwdarw 4-N-acetylglucosaminyltransferase gene elevates the kinetic efficiency of the encoded enzyme for both UDP-sugar donor and acceptor substrates. Journal of Biological Chemistry 272(30): 18580-18585

Elder, P.A.; Bell, S.M.; Knowles, M.A. 1994: Deletion of two regions on chromosome 4 in bladder carcinoma: definition of a critical 750kB region at 4p16.3. Oncogene 9(12): 3433-3436

Chen, L.C.; Matsumura, K.; Deng, G.; Kurisu, W.; Ljung, B.M.; Lerman, M.I.; Waldman, F.M.; Smith, H.S. 1994: Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Research 54(11): 3021-3024

Harland, D.L.; Robinson, W.A.; Franklin, W.A. 1997: Deletion of the p53 gene in a patient with aggressive burn scar carcinoma. Journal of Trauma 42(1): 104-107

Sheu, S.Y.; Lo, S.J. 1995: Deletion or alteration of hydrophobic amino acids at the first and the third transmembrane domains of hepatitis B surface antigen enhances its production in Escherichia coli. Gene 160(2): 179-184

Saeki, H.; Kuwata, S.; Nakagawa, H.; Shimada, S.; Tamaki, K.; Ishibashi, Y. 1998: Deletion pattern of the steroid sulphatase gene in Japanese patients with X-linked ichthyosis. British Journal of Dermatology 139(1): 96-98

Baranzini, S.E.; Giliberto, F.; Herrera, M.; Bernath, V.; Barreiro, C.; Garcia Erro, M.; Grippo, J.; Szijan, I. 1998: Deletion patterns in Argentine patients with Duchenne and Becker muscular dystrophy. Neurological Research 20(5): 409-414

Florentin, L.; Mavrou, A.; Kekou, K.; Metaxotou, C. 1995: Deletion patterns of Duchenne and Becker muscular dystrophies in Greece. Journal of Medical Genetics 32(1): 48-51

Pujia, A.; Motti, C.; Irace, C.; Cortese, C.; Biagiotti, L.; Mattioli, P.L.; Federici, G.; Gnasso, A. 1996: Deletion polymorphism in angiotensin converting enzyme gene associated with carotid wall thickening in a healthy male population. Coronary Artery Disease 7(1): 51-55

Furuya, K.; Yamaguchi, E.; Itoh, A.; Hizawa, N.; Ohnuma, N.; Kojima, J.; Kodama, N.; Kawakami, Y. 1996: Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 51(8): 777-780

Margaglione, M.; Celentano, E.; Grandone, E.; Vecchione, G.; Cappucci, G.; Giuliani, N.; Colaizzo, D.; Panico, S.; Mancini, F.P.; Di Minno, G. 1996: Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arteriosclerosis Thrombosis and Vascular Biology 16(2): 304-309

Frossard, P.M.; Obineche, E.N.; Elshahat, Y.I.; Lestringant, G.G. 1997: Deletion polymorphism in the angiotensin-converting enzyme gene is not associated with hypertension in a Gulf Arab population. Clinical Genetics 51(3): 211-213

Zingone, A.; Dominijanni, A.; Mele, E.; Marasco, O.; Melina, F.; Minchella, P.; Quaresima, B.; Tiano, M.T.; Gnasso, A.; Pujia, A. 1994: Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Human Genetics 94(2): 207-209

Perticone, F.; Ceravolo, R.; Cosco, C.; Trapasso, M.; Zingone, A.; Malatesta, P.; Perrotti, N.; Tramontano, D.; Mattioli, P.L. 1997: Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. Journal of the American College of Cardiology 29(2): 365-369

Winkelmann, B.R.; Nauck, M.; Klein, B.; Russ, A.P.; Böhm, B.O.; Siekmeier, R.; Ihnken, K.; Verho, M.; Gross, W.; März, W. 1996: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Annals of Internal Medicine 125(1): 19-25

Nakai, K.; Itoh, C.; Miura, Y.; Hotta, K.; Musha, T.; Itoh, T.; Miyakawa, T.; Iwasaki, R.; Hiramori, K. 1994: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 90(5): 2199-2202

Gharavi, A.G.; Lipkowitz, M.S.; Diamond, J.A.; Jhang, J.S.; Phillips, R.A. 1996: Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. American Journal of Cardiology 77(15): 1315-1319

Lapie, P.; Nasr, F.; Lepesant, J.A.; Deutsch, J. 1993: Deletion scanning of the regulatory sequences of the Fbp1 gene of Drosophila melanogaster using P transposase-induced deficiencies. Genetics 135(3): 801-816

Kwiatkowska, J.; Lisiecka, D.; Sowinska, J.; Marszal, E.; Emich-Widera, E.; Ciesielski, T.; Szczególa-Przymusiak, A.; Nuc, P.; Chlebowska, H.; Zimowski, J.; Galas-Zgorzalewicz, B.; Slomski, R. 1997: Deletion screening and carrier detection in Duchenne muscular dystrophy in Polish population via direct analysis of DNA and RNA transcripts. Biochimie 79(7): 439-448

Welihinda, J.; Karunanayake, E.H.; Jayasekara, R.; Peiris, J.B.; Pettersson, U.; Wadelius, C. 1993: Deletion screening of Sri Lankan Duchenne muscular dystrophy patients using the polymerase chain reaction. Annals of Tropical Paediatrics 13(1): 83-86

Renieri, A.; Bassi, M.T.; Galli, L.; Zhou, J.; Giani, M.; De Marchi, M.; Ballabio, A. 1994: Deletion spanning the 5' ends of both the COL4A5 and COL4A6 genes in a patient with Alport's syndrome and leiomyomatosis. Human Mutation 4(3): 195-198

Bushby, K.M.; Appleton, R.; Anderson, L.V.; Welch, J.L.; Kelly, P.; Gardner-Medwin, D. 1995: Deletion status and intellectual impairment in Duchenne muscular dystrophy. Developmental Medicine and Child Neurology 37(3): 260-269

Iemura, A.; Yano, H.; Ogasawara, S.; Yamaguchi, R.; Hisaka, T.; Utsunomiya, I.; Kojiro, M. 1997: Deletion type hepatocyte growth factor has different effects on growth and c-met expression in 10 different human hepatocellular carcinoma cell lines. International Journal of Oncology 10(6): 1167-1172

Feil, I.K.; Lerch, H.P.; Schomburg, D. 1994: Deletion variants of L-hydroxyisocaproate dehydrogenase. Probing substrate specificity. European Journal of Biochemistry 223(3): 857-863

Johnson, M.C.; Strauss, A.W.; Dowton, S.B.; Spray, T.L.; Huddleston, C.B.; Wood, M.K.; Slaugh, R.A.; Watson, M.S. 1995: Deletion within chromosome 22 is common in patients with absent pulmonary valve syndrome. American Journal of Cardiology 76(1): 66-69

Haataja, L.; Raffel, C.; Ledbetter, D.H.; Tanigami, A.; Petersen, D.; Heisterkamp, N.; Groffen, J. 1997: Deletion within the D17S34 locus in a primitive neuroectodermal tumor. Cancer Research 57(1): 32-34

Zhu, Q.; Zhang, M.; Rawlings, D.J.; Vihinen, M.; Hagemann, T.; Saffran, D.C.; Kwan, S.P.; Nilsson, L.; Smith, C.I.; Witte, O.N.; Chen, S.H.; Ochs, H.D. 1994: Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). Journal of Experimental Medicine 180(2): 461-470

Gupta, A.; Morby, A.P.; Turner, J.S.; Whitton, B.A.; Robinson, N.J. 1993: Deletion within the metallothionein locus of cadmium-tolerant Synechococcus PCC 6301 involving a highly iterated palindrome (HIP1). Molecular Microbiology 7(2): 189-195

Jagasia, A.; Sher, D.; Diaz, M.O. 1996: Deletion, mutation, or post-transcriptional downregulation, inactivate the INK4A gene in different leukemia or lymphoma cell lines. Ciencia e Cultura (Sao Paulo) 48(5-6): 347-350

Pomponio, R.J.; Narasimhan, V.; Reynolds, T.R.; Buck, G.A.; Povirk, L.F.; Wolf, B. 1996: Deletion/insertion mutation that causes biotinidase deficiency may result from the formation of a quasipalindromic structure. Human Molecular Genetics 5(10): 1657-1661

Multani, A.S.; Shah, V.C.; Singh, D.; Chakravarty, N.; Chinoy, N.J.; Pathak, S. 1997: Deletion/inversion in the X-chromosome and increased telomeric associations in a female with primary amenorrhea. Brazilian Journal of Genetics 20(3): 511-516

Kasahara, N. 1993: Deletional analysis of the human renin promoter: transcriptional activation by the SV40 enhancer enables identification of promoter regulatory elements in non-renin-expressing cells. Bulletin of Tokyo Medical and Dental University 40(2): 79-91

Mainville, C.A.; Sheehan, K.M.; Klaman, L.D.; Giorgetti, C.A.; Press, J.L.; Brodeur, P.H. 1996: Deletional mapping of fifteen mouse VH gene families reveals a common organization for three Igh haplotypes. Journal of Immunology 156(3): 1038-1046

Tan, J.A.M.ry Anne; Tay, S.H.ck John; Saha, N. 1995: Deletional types of alpha thalassemia in the Dravidian Indians of Singapore. Southeast Asian Journal of Tropical Medicine and Public Health 26(3): 550-554

Tan, J.A.; Tay, J.S.; Soemantri, A.; Kham, S.K.; Wong, H.B.; Lai, P.S.; Saha, N. 1992: Deletional types of alpha-thalassaemia in central Java. Human Heredity 42(5): 289-292

Pâques, F.; Wegnez, M. 1993: Deletions and amplifications of tandemly arranged ribosomal 5S genes internal to a P element occur at a high rate in a dysgenic context. Genetics 135(2): 469-476

Greenblatt, M.S.; Grollman, A.P.; Harris, C.C. 1996: Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model. Cancer Research 56(9): 2130-2136

Pinyol, M.; Hernandez, L.; Cazorla, M.; Balbín, M.; Jares, P.; Fernandez, P.L.; Montserrat, E.; Cardesa, A.; Lopez-Otín, C.; Campo, E. 1997: Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 89(1): 272-280

Stranks, G.; Height, S.E.; Mitchell, P.; Jadayel, D.; Yuille, M.A.; De Lord, C.; Clutterbuck, R.D.; Treleaven, J.G.; Powles, R.L.; Nacheva, E. 1995: Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood 85(4): 893-901

Srivenugopal, K.S.; Ali-Osman, F. 1996: Deletions and rearrangements inactivate the p16INK4 gene in human glioma cells. Oncogene 12(9): 2029-2034

Ballabio, A.; Andria, G. 1992: Deletions and translocations involving the distal short arm of the human X chromosome: review and hypotheses. Human Molecular Genetics 1(4): 221-227

Di Vinci, A.; Infusini, E.; Peveri, C.; Risio, M.; Rossini, F.P.; Giaretti, W. 1996: Deletions at chromosome 1p by fluorescence in situ hybridization are an early event in human colorectal tumorigenesis. Gastroenterology 111(1): 102-107

Bierne, H.; Ehrlich, S.D.; Michel, B. 1997: Deletions at stalled replication forks occur by two different pathways. EMBO Journal 16(11): 3332-3340

Schein, C.H.; Haugg, M. 1995: Deletions at the C-terminus of interferon gamma reduce RNA binding and activation of double-stranded-RNA cleavage by bovine seminal ribonuclease. Biochemical Journal 307: 123-127

Wang, L.K.; Shuman, S. 1997: Deletions at the carboxyl terminus of vaccinia DNA topoisomerase affect DNA binding and enhance distributivity in DNA relaxation. Biochemistry 36(13): 3909-3916

Wolff, D.J.; Gustashaw, K.M.; Zurcher, V.; Ko, L.; White, W.; Weiss, L.; Van Dyke, D.L.; Schwartz, S.; Willard, H.F. 1997: Deletions in Xq26.3-q27.3 including FMR1 result in a severe phenotype in a male and variable phenotypes in females depending upon the X inactivation pattern. Human Genetics 100(2): 256-261

Hu, L.J.; Laporte, J.; Kress, W.; Kioschis, P.; Siebenhaar, R.; Poustka, A.; Fardeau, M.; Metzenberg, A.; Janssen, E.A.; Thomas, N.; Mandel, J.L.; Dahl, N. 1996: Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430 kb region. Human Molecular Genetics 5(1): 139-143

Horn, M.; Humphries, P.; Kunisch, M.; Marchese, C.; Apfelstedt-Sylla, E.; Fugi, L.; Zrenner, E.; Kenna, P.; Gal, A.; Farrar, J. 1992: Deletions in exon 5 of the human rhodopsin gene causing a shift in the reading frame and autosomal dominant retinitis pigmentosa. Human Genetics 90(3): 255-257

Hoatlin, M.E.; Ferro, F.E.; Geib, R.W.; Fox, M.T.; Kozak, S.L.; Kabat, D. 1995: Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions for erythroleukemia. Journal of Virology 69(2): 856-863

Antignac, C.; Knebelmann, B.; Drouot, L.; Gros, F.; Deschênes, G.; Hors-Cayla, M.C.; Zhou, J.; Tryggvason, K.; Grünfeld, J.P.; Broyer, M. 1994: Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression. Journal of Clinical Investigation 93(3): 1195-1207

Santón, A.; Manzanal, A.I.; Campo, E.; Bellas, C. 1995: Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. Clinical Molecular Pathology 48(4): M184-M187

Zappata, S.; Tiziano, F.; Neri, G.; Brahe, C. 1996: Deletions in the SMN gene in infantile and adult spinal muscular atrophy patients from the same family. Human Genetics 97(3): 315-318

Vickerman, M.M.; Clewell, D.B. 1997: Deletions in the carboxyl-terminal region of Streptococcus gordonii glucosyltransferase affect cell-associated enzyme activity and sucrose-associated accumulation of growing cells. Applied and Environmental Microbiology 63(5): 1667-1673

DeLisser, H.M.; Chilkotowsky, J.; Yan, H.C.; Daise, M.L.; Buck, C.A.; Albelda, S.M. 1994: Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties. Journal of Cell Biology 124(1-2): 195-203

MacDonald, J.I.; Meakin, S.O. 1996: Deletions in the extracellular domain of rat trkA lead to an altered differentiative phenotype in neurotrophin responsive cells. Molecular and Cellular Neurosciences 7(5): 371-390

Sharp, R.E.; Chapman, S.K.; Reid, G.A. 1996: Deletions in the interdomain hinge region of flavocytochrome b2: effects on intraprotein electron transfer. Biochemistry 35(3): 891-899

Ramesh, N.; Fuleihan, R.; Ramesh, V.; Lederman, S.; Yellin, M.J.; Sharma, S.; Chess, L.; Rosen, F.S.; Geha, R.S. 1993: Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). International Immunology 5(7): 769-773

Eldar, H.; Ben-Chaim, J.; Livneh, E. 1992: Deletions in the regulatory or kinase domains of protein kinase C-alpha cause association with the cell nucleus. Experimental Cell Research 202(2): 259-266

Erdem, H.; Pehlivan, S.; Topaloğlu, H.; Yalnizoğlu, D.; Akçören, Z. 1996: Deletions in the survival motor neuron gene in Turkish spinal muscular atrophy patients. Journal of Inherited Metabolic Disease 19(6): 724-728

Rodrigues, N.R.; Owen, N.; Talbot, K.; Ignatius, J.; Dubowitz, V.; Davies, K.E. 1995: Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Human Molecular Genetics 4(4): 631-634

Wonerow, P.; Schöneberg, T.; Schultz, G.; Gudermann, T.; Paschke, R. 1998: Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. Journal of Biological Chemistry 273(14): 7900-7905

Cizeau, J.; Decoville, M.; Leng, M.; Locker, D. 1994: Deletions induced in the white and vermilion genes of Drosophila melanogaster by the antitumor drug cis-dichlorodiammineplatinum(II). Mutation Research 311(1): 31-38

Gaidano, G.; Hauptschein, R.S.; Parsa, N.Z.; Offit, K.; Rao, P.H.; Lenoir, G.; Knowles, D.M.; Chaganti, R.S.; Dalla-Favera, R. 1992: Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 80(7): 1781-1787

Sozzi, G.; Miozzo, M.; Donghi, R.; Pilotti, S.; Cariani, C.T.; Pastorino, U.; Della Porta, G.; Pierotti, M.A. 1992: Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Research 52(21): 6079-6082

Krantz, I.D.; Rand, E.B.; Genin, A.; Hunt, P.; Jones, M.; Louis, A.A.; Graham, J.M.; Bhatt, S.; Piccoli, D.A.; Spinner, N.B. 1997: Deletions of 20p12 in Alagille syndrome: Frequency and molecular characterization. American Journal of Medical Genetics 70(1): 80-86

Park, W.S.; Oh, M.J.; Lee, H.K.; Lee, K.O.; Rhyu, M.G.; Dong, S.M.; Lee, J.Y.; Kim, S.H. 1996: Deletions of 9p21 and TP53 in bladder cancer. Journal of Korean Medical Science 11(3): 233-238

Andreasson, P.; Johansson, B.; Arheden, K.; Billström, R.; Mitelman, F.; Höglund, M. 1997: Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosomes and Cancer 19(2): 77-83

Swartley, J.S.; Mcallister, C.F.; Hajjeh, R.A.; Heinrich, D.W.; Stephens, D.S. 1993: Deletions of Tn916-like transposons are implicated in tetM-mediated resistance in pathogenic Neisseria. Molecular Microbiology 10(2): 299-310

Zhang, X.; Xu, H.J.; Murakami, Y.; Sachse, R.; Yashima, K.; Hirohashi, S.; Hu, S.X.; Benedict, W.F.; Sekiya, T. 1994: Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Research 54(15): 4177-4182

Tyson, J.; Malcolm, S.; Thomas, P.K.; Harding, A.E. 1996: Deletions of chromosome 17p11.2 in multifocal neuropathies. Annals of Neurology 39(2): 180-186

Wistuba, I.I.; Montellano, F.D.; Milchgrub, S.; Virmani, A.K.; Behrens, C.; Chen, H.; Ahmadian, M.; Nowak, J.A.; Muller, C.; Minna, J.D.; Gazdar, A.F. 1997: Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Research 57(15): 3154-3158

Veitia, R.; Nunes, M.; Brauner, R.; Doco-Fenzy, M.; Joanny-Flinois, O.; Jaubert, F.; Lortat-Jacob, S.; Fellous, M.; McElreavey, K. 1997: Deletions of distal 9p associated with 46,XY male to female sex reversal: definition of the breakpoints at 9p23.3-p24.1. Genomics 41(2): 271-274

Yamada, Y.; Hatta, Y.; Murata, K.; Sugawara, K.; Ikeda, S.; Mine, M.; Maeda, T.; Hirakata, Y.; Kamihira, S.; Tsukasaki, K.; Ogawa, S.; Hirai, H.; Koeffler, H.P.; Tomonaga, M. 1997: Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(5): 1778-1785

Abell, A.; Liu, X.; Segaloff, D.L. 1996: Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor. Journal of Biological Chemistry 271(8): 4518-4527

Li, X.; Zhang, G.; Ngo, N.; Zhao, X.; Kain, S.R.; Huang, C.C. 1997: Deletions of the Aequorea victoria green fluorescent protein define the minimal domain required for fluorescence. Journal of Biological Chemistry 272(45): 28545-28549

Gombart, A.F.; Morosetti, R.; Miller, C.W.; Said, J.W.; Koeffler, H.P. 1995: Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas. Blood 86(4): 1534-1539

Schiöth, H.B.; Petersson, S.; Muceniece, R.; Szardenings, M.; Wikberg, J.E. 1997: Deletions of the N-terminal regions of the human melanocortin receptors. Febs Letters 410(2-3): 223-228

Nobori, T.; Miura, K.; Wu, D.J.; Lois, A.; Takabayashi, K.; Carson, D.A. 1994: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368(6473): 753-756

Zedenius, J.; Wallin, G.; Svensson, A.; Bovèe, J.; Höög, A.; Bäckdahl, M.; Larsson, C. 1996: Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Human Genetics 97(3): 299-303

Velloso, E.R.; Michaux, L.; Ferrant, A.; Hernandez, J.M.; Meeus, P.; Dierlamm, J.; Criel, A.; Louwagie, A.; Verhoef, G.; Boogaerts, M.; Michaux, J.L.; Bosly, A.; Mecucci, C.; Van den Berghe, H. 1996: Deletions of the long arm of chromosome 7 in myeloid disorders: Loss of band 7q32 implies worst prognosis. British Journal of Haematology 92(3): 574-581

Kees, U.R.; Ranford, P.R.; Hatzis, M. 1996: Deletions of the p16 gene in pediatric leukemia and corresponding cell lines. Oncogene 12(10): 2235-2239

Belge, G.; Bruckmann, S.; Thode, B.; Bartnitzke, S.; Bullerdiek, J. 1996: Deletions of the short arm of chromosome 2 characterize a new cytogenetic subgroup of benign thyroid tumors. Genes Chromosomes and Cancer 16(2): 149-151

Heyman, M.; Grandér, D.; Bröndum-Nielsen, K.; Liu, Y.; Söderhäll, S.; Einhorn, S. 1993: Deletions of the short arm of chromosome 9, including the interferon-alpha/-beta genes, in acute lymphocytic leukemia. Studies on loss of heterozygosity, parental origin of deleted genes and prognosis. International Journal of Cancer 54(5): 748-753

Cobben, J.M.; van der Steege, G.; Grootscholten, P.; de Visser, M.; Scheffer, H.; Buys, C.H. 1995: Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. American Journal of Human Genetics 57(4): 805-808

Albert, P.R.; Liston, D. 1993: Deletions of the synenkephalin domain which do not alter cell-specific proteolytic processing or secretory targeting of human proenkephalin. Journal of Neurochemistry 60(4): 1325-1334

Lindblom, A.; Rotstein, S.; Skoog, L.; Nordenskjöld, M.; Larsson, C. 1993: Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. Cancer Research 53(16): 3707-3711

Ruttledge, M.H.; Xie, Y.G.; Han, F.Y.; Peyrard, M.; Collins, V.P.; Nordenskjöld, M.; Dumanski, J.P. 1994: Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes and Cancer 10(2): 122-130

von Deimling, A.; Louis, D.N.; Menon, A.G.; von Ammon, K.; Petersen, I.; Ellison, D.; Wiestler, O.D.; Seizinger, B.R. 1993: Deletions on the long arm of chromosome 17 in pilocytic astrocytoma. Acta Neuropathologica 86(1): 81-85

Kayes, L.M.; Burke, W.; Riccardi, V.M.; Bennett, R.; Ehrlich, P.; Rubenstein, A.; Stephens, K. 1994: Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. American Journal of Human Genetics 54(3): 424-436

Cnossen, M.H.; van der Est, M.N.; Breuning, M.H.; van Asperen, C.J.; Breslau-Siderius, E.J.; van der Ploeg, A.T.; de Goede-Bolder, A.; van den Ouweland, A.M.; Halley, D.J.; Niermeijer, M.F. 1997: Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1?. Human Mutation 9(5): 458-464

Abadjieva, A.; Webb, M.; Patel, J.; Zinkevich, V.; Firman, K. 1994: Deletions within the DNA recognition subunit of M.EcoR124i that identify a region involved in protein-protein interactions between HsdS and HsdM. Journal of Molecular Biology 241(1): 35-43

Knecht, H.; Bachmann, E.; Brousset, P.; Sandvej, K.; Nadal, D.; Bachmann, F.; Odermatt, B.F.; Delsol, G.; Pallesen, G. 1993: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82(10): 2937-2942

Shea, C.; Lovelace, L.J.; Smith Somerville, H.E. 1995: Deleya marina as a model organism for studies of bacterial colonization and biofilm formation. Journal of Industrial Microbiology 15(4): 290-296

Schmitt, O. 1992: Delias dollyae, new species from Papua New Guinea (Lepidoptera Pieridae). Bulletin de la Societe Sciences Nat 1992(75-76): 68

Steinberg, G.K.; Drake, C.G.; Peerless, S.J. 1993: Deliberate basilar or vertebral artery occlusion in the treatment of intracranial aneurysms. Immediate results and long-term outcome in 201 patients. Journal of Neurosurgery 79(2): 161-173

Sharrock, N.E.; Bading, B.; Mineo, R.; Blumenfeld, J.D. 1994: Deliberate hypotensive epidural anesthesia for patients with normal and low cardiac output. Anesthesia and Analgesia 79(5): 899-904

Baker, K.Z.; Young, W.L.; Stone, J.G.; Kader, A.; Baker, C.J.; Solomon, R.A. 1994: Deliberate mild intraoperative hypothermia for craniotomy. Anesthesiology 81(2): 361-367

Pavlakis, N.; Pollock, C.A.; McLean, G.; Bartrop, R. 1996: Deliberate overdose of uranium: toxicity and treatment. Nephron 72(2): 313-317

McLAUGHLIN; Miller; Warwick 1996: Deliberate self-harm in adolescents: Hopelessness, depression, problems and problem-solving. Journal of Adolescence 19(6): 523-532

Nowers, M. 1993: Deliberate self-harm in the elderly: A survey of one London Borough. International Journal of Geriatric Psychiatry 8(7): 609-614

Vlachos, I.O.; Bouras, N.; Watson, J.P.; Rosen, B.K. 1994: Deliberate self-harm referrals. European Journal of Psychiatry 8(1): 25-28

Hawton, K.; Fagg, J. 1992: Deliberate self-poisoning and self-injury in adolescents. A study of characteristics and trends in Oxford, 1976-89. British Journal of Psychiatry: the Journal of Mental Science 161: 816-823

Hawton, K.; Fagg, J.; Simkin, S. 1996: Deliberate self-poisoning and self-injury in children and adolescents under 16 years of age in Oxford, 1976-1993. British Journal of Psychiatry: the Journal of Mental Science 169(2): 202-208

Saadeh, A., M.; Ammari, F., L.; Zaidan, Z., A.J.; Al-Ali, M. 1995: Deliberate self-poisoning with drugs and household products in North Jordan: A 4-year review. Saudi Medical Journal 16(6): 527-531

Kelleher, M.J.; Kelleher, M.J.; Daly, M.; Corcoran, P.; Daly, F.; Crowley, M.J.; Keeley, H. 1996: Deliberate self-poisoning, unemployment and public health. Suicide and Life-Threatening Behavior 26(4): 365-373

Shimizu, N.; Kawazoe, Y. 1996: Delicate and crucial pH dependence in permeabilization of cultured mammalian cells by vortex-stirring with a high molecular weight polyacrylic acid. Biological and Pharmaceutical Bulletin 19(11): 1533-1535

Craver, R.D.; McGarry, P. 1994: Delicate longitudinal nuclear grooves in childhood ependymomas. Archives of Pathology and Laboratory Medicine 118(9): 919-921

Kwong, Y.L.; Todd, D. 1997: Delicious poison: arsenic trioxide for the treatment of leukemia. Blood 89(9): 3487-3488

Balkwill, M.-Jane; Balkwill, K. 1997: Delimitation and infra-generic classification of Barleria (Acanthaceae). Kew Bulletin 52(3): 535-573

Molero, J.; Mus, M.; Rossello, J.A.; Valles, J. 1993: Delimitation and infraspecific variations in Euphorbia maresii Knoche, endemic species of Balearic Islands. Acta Botanica Gallica 140(1): 69-79

Vollesen, K. 1994: Delimitation of Angkalanthus (Acanthaceae: Justicieae) and the new genus Chorisochora. Kew Bulletin 49(3): 469-479

Yao, Y.J.; Spooner, B.M. 1996: Delimitation of Boubovia and Pulvinula. Mycological Research 100(2): 194

Bougher, N.L.; Castellano, M.A. 1993: Delimitation of Hymenogaster sensu stricto and four new segregate genera. Mycologia 85(2): 273-293

Marti, J.M.; Miller, A. 1994: Delimitation of safe corridors for the insertion of external fixator pins in the dog: 1. Hindlimb. Journal of Small Animal Practice 35(1): 16-23

Marti, J.M.; Miller, A. 1994: Delimitation of safe corridors for the insertion of external fixator pins in the dog: 2. Forelimb. Journal of Small Animal Practice 35(2): 78-85

Bragazza, L. 1996: Delimitation of the aerobic peat layer in a Sphagnum mire on the southern Alps. Oecologia Montana 5(1): 41-46

Alvarez-Vallina, L.; González, A.; Gambón, F.; Kreisler, M.; Díaz-Espada, F. 1993: Delimitation of the proliferative stages in the human thymus indicates that cell expansion occurs before the expression of CD3 (T cell receptor). Journal of Immunology 150(1): 8-16

Carreras, J.; Carrillo, E.; Masalles, R.M.; Ninot, J.M.; Soriano, I.; Vigo, J. 1996: Delimitation of the supra-forest zone in the Catalan Pyrenees. Bulletin de la Societe Linneenne de Provence 47: 27-36

Olde, P., M.; Molyneux, W.M. 1994: Delimitation of two new species from the Grevillea victoriae alliance (Proteaceae: Grevilleoideae). Telopea 5(4): 781-787

Abbott, S.P.; Sigler, L.; Currah, R.S. 1996: Delimitation, typification, and taxonomic placement of the genus Arachnomyces. Systema Ascomycetum 14(2): 79-85

Altherr, M.R.; Wright, T.J.; Denison, K.; Perez-Castro, A.V.; Johnson, V.P. 1997: Delimiting the Wolf-Hirschhorn syndrome critical region to 750 kilobase pairs. American Journal of Medical Genetics 71(1): 47-53

Kloos, W.E.; Ballard, D.N.; George, C.G.; Webster, J.A.; Hubner, R.J.; Ludwig, W.; Schleifer, K.H.; Fiedler, F.; Schubert, K. 1998: Delimiting the genus Staphylococcus through description of Macrococcus caseolyticus gen. nov., comb. nov. and Macrococcus equipericus sp. nov., Macrococcus bovicus sp. nov. and Macrococcus carouselicus sp. nov. International Journal of Systematic Bacteriology 48(3 Part 4): 859-877

Perugi, G.; Toni, C.; Benedetti, A.; Simonetti, B.; Simoncini, M.; Torti, C.; Musetti, L.; Akiskal, H.S. 1998: Delineating a putative phobic-anxious temperament in 126 panic-agoraphobic patients: toward a rapprochement of European and US views. Journal of Affective Disorders 47(1-3): 11-23

Chen, Y.; Plouffe, C.; Ménard, R.; Storer, A.C. 1996: Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity. Febs Letters 393(1): 24-26

Stoessell, R.K. 1997: Delineating the chemical composition of the salinity source of saline ground waters: An example from east-central Concordia Parish, Louisiana. Ground Water 35(3): 409-417

Rizzo, D.M.; Harrington, T.C. 1993: Delineation and biology of clones of Armillaria ostoyae, Armillaria gemina and Armillaria calvescens. Mycologia 85(2): 164-174

Loewe, C.; Oberhuber, G.; Loewe, R.; Frank, H. 1998: Delineation and characterization of atherosclerotic plaque lesions by magnetic resonance imaging. Zeitschrift fuer Kardiologie 87(8): 622-629

Angström, J.; Teneberg, S.; Karlsson, K.A. 1994: Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes. Proceedings of the National Academy of Sciences of the United States of America 91(25): 11859-11863

Schesser, K.; Frithz-Lindsten, E.; Wolf-Watz, H. 1996: Delineation and mutational analysis of the Yersinia pseudotuberculosis YopE domains which mediate translocation across bacterial and eukaryotic cellular membranes. Journal of Bacteriology 178(24): 7227-7233

Boudraa, A.E.; Champier, J.; Cinotti, L.; Bordet, J.C.; Lavenne, F.; Mallet, J.J. 1996: Delineation and quantitation of brain lesions by fuzzy clustering in positron emission tomography. Computerized Medical Imaging and Graphics: the Official Journal of the Computerized Medical Imaging Society 20(1): 31-41

Shimonkevitz, R.; Boen, E.; Malmstrom, S.; Brown, E.; Hurley, J.M.; Kotzin, B.L.; Matsumura, M. 1996: Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1. Infection and Immunity 64(4): 1133-1139

Robinson, W.P.; Waslynka, J.; Bernasconi, F.; Wang, M.; Clark, S.; Kotzot, D.; Schinzel, A. 1996: Delineation of 7q11.2 deletions associated with Williams-Beuren syndrome and mapping of a repetitive sequence to within and to either side of the common deletion. Genomics 34(1): 17-23

Strauch, M.A. 1995: Delineation of AbrB-binding sites on the Bacillus subtilis spo0H, kinB, ftsAZ, and pbpE promoters and use of a derived homology to identify a previously unsuspected binding site in the bsuB1 methylase promote. Journal of Bacteriology 177(23): 6999-7002

Susser, E.; Varma, V.K.; Malhotra, S.; Conover, S.; Amador, X.F. 1995: Delineation of acute and transient psychotic disorders in a developing country setting. British Journal of Psychiatry: the Journal of Mental Science 167(2): 216-219

Dickason, R.R.; Huston, M.M.; Huston, D.P. 1996: Delineation of IL-5 domains predicted to engage the IL-5 receptor complex. Journal of Immunology 156(3): 1030-1037

Galy, A.H.; Cen, D.; Travis, M.; Chen, S.; Chen, B.P. 1995: Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow. Blood 85(10): 2770-2778

Korvatska, E.; Munier, F.L.; Zografos, L.; Ahmad, F.; Faggioni, R.; Dolivo-Beuret, A.; Uffer, S.; Pescia, G.; Schorderet, D.F. 1996: Delineation of a 1-cM region on distal 5q containing the locus for corneal dystrophies Groenouw type I and lattice type I and exclusion of the candidate genes SPARC and LOX. European Journal of Human Genetics: Ejhg 4(4): 214-218

Chen, M.R.; Zong, J.; Hayward, S.D. 1994: Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein. Virology 205(2): 486-495

Gérard, B.; Cavé, H.; Guidal, C.; Dastugue, N.; Vilmer, E.; Grandchamp, B. 1997: Delineation of a 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm. Leukemia 11(2): 228-232

Perez-Fernandez, R.; Arce, V.; Freedman, L.P. 1993: Delineation of a DNA recognition element for the vitamin D3 receptor by binding site selection. Biochemical and Biophysical Research Communications 192(2): 728-737

Koyasu, S.; Tse, A.G.; Moingeon, P.; Hussey, R.E.; Mildonian, A.; Hannisian, J.; Clayton, L.K.; Reinherz, E.L. 1994: Delineation of a T-cell activation motif required for binding of protein tyrosine kinases containing tandem SH2 domains. Proceedings of the National Academy of Sciences of the United States of America 91(14): 6693-6697

Bühler, E.M.; Bienz, G.; Straumann, E.; Bösch, N. 1996: Delineation of a clinical syndrome caused by mosaic trisomy 15. American Journal of Medical Genetics 62(2): 109-112

Bartsch, O.; Wuyts, W.; Van Hul, W.; Hecht, J.T.; Meinecke, P.; Hogue, D.; Werner, W.; Zabel, B.; Hinkel, G.K.; Powell, C.M.; Shaffer, L.G.; Willems, P.J. 1996: Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation, caused by deletions in the short arm of chromosome 11. American Journal of Human Genetics 58(4): 734-742

Rizzu, P.; Haddad, B.R.; Vallcorba, I.; Alonso, A.; Ferro, M.T.; Garcia-Sagredo, J.M.; Baldini, A. 1997: Delineation of a duplication map of chromosome 3q: A new case confirms the exclusion of 3q25-q26.2 from the duplication 3q syndrome critical region. American Journal of Medical Genetics 68(4): 428-432

Conte, R.A.; Kleyman, S.M.; Kharode, C.; Verma, R.S. 1997: Delineation of a ring chromosome 16 by the FISH-technique: A case report with review. Clinical Genetics 51(3): 196-199

Schnoebelen, D.J.; Bugliosi, E.F.; Krothe, N.C. 1995: Delineation of a saline ground-water boundary from borehole geophysical data. Ground Water 33(6): 965-976

Stevenson, D.; Colman, K.L.; Davison, A.J. 1994: Delineation of a sequence required for nuclear localization of the protein encoded by varicella-zoster virus gene 61. Journal of General Virology 75: 3229-3233

Dahlman-Wright, K.; Almlöf, T.; McEwan, I.J.; Gustafsson, J.A.; Wright, A.P. 1994: Delineation of a small region within the major transactivation domain of the human glucocorticoid receptor that mediates transactivation of gene expression. Proceedings of the National Academy of Sciences of the United States of America 91(5): 1619-1623

Saeed, M.; Wendland, M.F.; Yu, K.K.; Higgins, C.B. 1992: Delineation of acute myocardial infarction with dysprosium DTPA-BMA: Influence of dose of magnetic susceptibility contrast medium. Journal of the American College of Cardiology 20(7): 1634-1641

Bryant, W.P.; Bergert, E.R.; Morris, J.C. 1994: Delineation of amino acid residues within hTSHr 256-275 that participate in hormone binding. Journal of Biological Chemistry 269(49): 30935-30938

Hadlock, K.G.; Goh, C.J.; Bradshaw, P.A.; Perkins, S.; Lo, J.; Kaplan, J.E.; Khabbaz, R.; Foung, S.K. 1995: Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein. Blood 86(4): 1392-1399

Norregaard, L.; Frederiksen, D.; Nielsen, E.O.; Gether, U. 1998: Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO Journal 17(15): 4266-4273

Jucovic, M.; Poteete, A.R. 1998: Delineation of an evolutionary salvage pathway by compensatory mutations of a defective lysozyme. Protein Science: a Publication of the Protein Society 7(10): 2200-2209

Moebius, U.; Pallai, P.; Harrison, S.C.; Reinherz, E.L. 1993: Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding. Proceedings of the National Academy of Sciences of the United States of America 90(17): 8259-8263

Hixson, D.C.; Affigne, S.; Faris, R.A.; McBride, A.C. 1996: Delineation of antigenic pathways of ethionine-induced liver cancer in the rat. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 64(2): 79-90

Nagayoshi, K.; Okada, M.; Monzen, Y.; Kimura, S.; Hamanaka, Y.; Ochi, M.; Hayashi, K. 1997: Delineation of calf deep veins using 2D-TOF MR venography without contrast media: efficacy of tourniquet and leg-warming. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 57(11): 647-652

Fruehauf, S.; Veldwijk, M.R.; Krämer, A.; Haas, R.; Zeller, W.J. 1998: Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy. Stem Cells 16(4): 271-279

Davidson, N.J.; Boyd, R.L. 1992: Delineation of chicken thymocytes by CD3-TCR complex, CD4 and CD8 antigen expression reveals phylogenically conserved and novel thymocyte subsets. International Immunology 4(10): 1175-1182

Naganagowda, G.A.; Gururaja, T.L.; Levine, M.J. 1998: Delineation of conformational preferences in human salivary statherin by 1H, 31P NMR and CD studies: sequential assignment and structure-function correlations. Journal of Biomolecular Structure and Dynamics 16(1): 91-107

Courtois, M.; Mechem, C.J.; Barzilai, B.; Gutierrez, F.; Ludbrook, P.A. 1994: Delineation of determinants of left ventricular early filling. Saline versus blood infusion. Circulation 90(4): 2041-2050

Giros, B.; Wang, Y.M.; Suter, S.; McLeskey, S.B.; Pifl, C.; Caron, M.G. 1994: Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. Journal of Biological Chemistry 269(23): 15985-15988

Fortin, M.-Josee; Drapeau, P. 1995: Delineation of ecological boundaries: Comparison of approaches and significance tests. Oikos 72(3): 323-332

Shetty, S.S.; DelGrande, D.; Savage, P.; Ksander, G.M.; Jeng, A.Y. 1995: Delineation of endothelin receptor subtypes in rat and rabbit aortas. Journal of Cardiovascular Pharmacology 26(Suppl): S310-S313

Peter, M.G.; Davenport, A.P. 1995: Delineation of endothelin receptors in human left ventricular smooth-muscle cells. Journal of Cardiovascular Pharmacology 26(Suppl): S355-S357

Bagavant, H.; Yurewicz, E.C.; Sacco, A.G.; Talwar, G.P.; Gupta, S.K. 1993: Delineation of epitopes on porcine zona pellucida relevant for binding of sperm to oocyte using monoclonal antibodies. Journal of Reproductive Immunology 23(3): 265-279

Olesen, G.; Carlsen, I.; Skovbo, A.; Hokland, M.; Hokland, P. 1998: Delineation of erythropoiesis in normal and malignant bone marrow using monoclonal antibody AS-E1 directed against transferrin receptors (CD71). European Journal of Haematology 60(1): 53-60

Hauff, P.; Fritzsch, T.; Reinhardt, M.; Weitschies, W.; Lüders, F.; Uhlendorf, V.; Heldmann, D. 1997: Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Investigative Radiology 32(2): 94-99

Tardif, J.C.; Vannan, M.A.; Taylor, K.; Schwartz, S.L.; Pandian, N.G. 1994: Delineation of extended lengths of coronary arteries by multiplane transesophageal echocardiography. Journal of the American College of Cardiology 24(4): 909-919

Abadie-Fauconnier, L.; Carosella, E.D.; Gluckman, E.; Mansur, I.G.; Menier, C.; Boumsell, L.; Bensussan, A. 1998: Delineation of human cord blood hematopoietic progenitor cell subsets with a unique monoclonal antibody AY19. Tissue Antigens 51(5): 520-527

Lal, R.B. 1996: Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 13(Suppl): S170-S178

Ariza, M.A.; Valero-Guillén, P.L. 1994: Delineation of molecular species of a family of diacyltrehaloses from Mycobacterium fortuitum by mass spectrometry. Fems Microbiology Letters 119(3): 279-282

Conversano, A.; Walsh, J.F.; Geltman, E.M.; Perez, J.E.; Bergmann, S.R.; Gropler, R.J. 1996: Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. American Heart Journal 131(3): 440-450

Grandin, C.; Wijns, W.; Melin, J.A.; Bol, A.; Robert, A.R.; Heyndrickx, G.R.; Michel, C.; Vanoverschelde, J.L. 1995: Delineation of myocardial viability with PET. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 36(9): 1543-1552

Stahl, J.; Gough, N.M. 1993: Delineation of positive and negative control elements within the promoter region of the murine leukemia inhibitory factor (LIF) gene. Cytokine 5(4): 386-393

Donovan, J.J.; Frysinger, K.W. 1997: Delineation of preferred-flow paths by response to transient lagoon exfiltration. Ground Water 35(6): 990-996,.-.

Morikawa, J.; Habuchi, Y.; Nishio, M.; Yamamoto, T.; Tanaka, H.; Kashima, K. 1996: Delineation of premature P waves on four-dimensional electrocardiography, a new display of electrical forces by computer techniques. Angiology 47(11): 1101-1106

Yachie, A.; Konno, A.; Ohta, K.; Wada, T.; Seki, H.; Taniguchi, N.; Miyawaki, T. 1995: Delineation of producing ability of IgG and IgA subclasses by naive B cells in newborn infants and adult individuals. Clinical and Experimental Immunology 102(1): 204-209

Mcdonald, C.F.; Hutchinson, P.; Atkins, R.C. 1993: Delineation of pulmonary alveolar macrophage subpopulations by flow cytometry in normal subjects and in patients with lung cancer. Clinical and Experimental Immunology 91(1): 126-130

Yi, M.; Nakamoto, Y.; Kaneko, S.; Yamashita, T.; Murakami, S. 1997: Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2. Virology 231(1): 119-129

Marx, G.R.; Fulton, D.R.; Pandian, N.G.; Vogel, M.; Cao, Q.L.; Ludomirsky, A.; Delabays, A.; Sugeng, L.; Klas, B. 1995: Delineation of site, relative size and dynamic geometry of atrial septal defects by real-time three-dimensional echocardiography. Journal of the American College of Cardiology 25(2): 482-490

Viersbach, R.; Engels, H.; Gamerdinger, U.; Hansmann, M. 1998: Delineation of supernumerary marker chromosomes in 38 patients. American Journal of Medical Genetics 76(4): 351-358

Dickson, P.W.; Jennings, I.G.; Cotton, R.G. 1994: Delineation of the catalytic core of phenylalanine hydroxylase and identification of glutamate 286 as a critical residue for pterin function. Journal of Biological Chemistry 269(32): 20369-20375

Thompson, G.; Owen, D.; Chalk, P.A.; Lowe, P.N. 1998: Delineation of the Cdc42/Rac-binding domain of p21-activated kinase. Biochemistry 37(21): 7885-7891

Putnam, E.A.; Cho, M.; Zinn, A.B.; Towbin, J.A.; Byers, P.H.; Milewicz, D.M. 1996: Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. American Journal of Medical Genetics 62(3): 233-242

Boyhan, A.; Smith, D.; Charles, I.G.; Saqi, M.; Lowe, P.N. 1997: Delineation of the arginine- and tetrahydrobiopterin-binding sites of neuronal nitric oxide synthase. Biochemical Journal 323: 131-139

Di Rocco, R.J.; Bauer, A.A.; Pirro, J.P.; Kuczynski, B.L.; Belnavis, L.; Chan, Y.W.; Linder, K.E.; Narra, R.K.; Nowotnik, D.P.; Nunn, A.D. 1997: Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole. Nuclear Medicine and Biology 24(3): 201-207

Tamura, A.; Akagi, T.; Nakazawa, N.; Kashima, K.; Nakamura, S.; Karpas, A.; Silverman, G.A.; Morishima, Y.; Taniwaki, M.; Seto, M. 1998: Delineation of the breakpoint at 18q21.1 in a cell line (Karpas1106) derived from mediastinal B-cell lymphoma by fluorescence in situ hybridization with multiple YAC clones. International Journal of Cancer 78(1): 100-105

Wagenknecht-Wiesner, A.; Weidmann, M.; Braun, V.; Leukel, P.; Moos, M.; von Eichel-Streiber, C. 1997: Delineation of the catalytic domain of Clostridium difficile toxin B-10463 to an enzymatically active N-terminal 467 amino acid fragment. Fems Microbiology Letters 152(1): 109-116

Wu, Y.Q.; Sutton, V.R.; Nickerson, E.; Lupski, J.R.; Potocki, L.; Korenberg, J.R.; Greenberg, F.; Tassabehji, M.; Shaffer, L.G. 1998: Delineation of the common critical region in Williams syndrome and clinical correlation of growth, heart defects, ethnicity, and parental origin. American Journal of Medical Genetics 78(1): 82-89

Mackensen, A.; Herbst, B.; Köhler, G.; Wolff-Vorbeck, G.; Rosenthal, F.M.; Veelken, H.; Kulmburg, P.; Schaefer, H.E.; Mertelsmann, R.; Lindemann, A. 1995: Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro. Blood 86(7): 2699-2707

Grady, E.F.; Garland, A.M.; Gamp, P.D.; Lovett, M.; Payan, D.G.; Bunnett, N.W. 1995: Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. Molecular Biology of the Cell 6(5): 509-524

Moreno, E.; Lanne, B.; Vázquez, A.M.; Kawashima, I.; Tai, T.; Fernández, L.E.; Karlsson, K.A.; Angström, J.; Pérez, R. 1998: Delineation of the epitope recognized by an antibody specific for N-glycolylneuraminic acid-containing gangliosides. Glycobiology 8(7): 695-705

Liang, X.; Pyne, C.; Li, Y.; Babiuk, L.A.; Kowalski, J. 1995: Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry. Virology 207(2): 429-441

Gasparini, S.; Danse, J.M.; Lecoq, A.; Pinkasfeld, S.; Zinn-Justin, S.; Young, L.C.; de Medeiros, C.C.; Rowan, E.G.; Harvey, A.L.; Ménez, A. 1998: Delineation of the functional site of alpha-dendrotoxin. the functional topographies of dendrotoxins are different but share a conserved core with those of other Kv1 potassium channel-blocking toxins. Journal of Biological Chemistry 273(39): 25393-25403

Kraft, G., T.; Wynne, M., J. 1996: Delineation of the genera Struvea Sonder and Phyllodictyon J. E. Gray (Cladophorales, Chlorophyta). Phycological Research 44(3): 129-142

Rajadhyaksha, M.; Thanavala, Y. 1995: Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide. Proceedings of the National Academy of Sciences of the United States of America 92(5): 1575-1579

Kask, K.; Berthold, M.; Kahl, U.; Nordvall, G.; Bartfai, T. 1996: Delineation of the peptide binding site of the human galanin receptor. EMBO Journal 15(2): 236-244

Gallin, J.I. 1993: Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood. International Journal of Tissue Reactions 15(3): 99-103

Zhu, M.H.; Berry, J.A.; Russell, S.M.; Leonard, W.J. 1998: Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta. Journal of Biological Chemistry 273(17): 10719-10725

Patel, S.D.; Monaco, J.J.; McDevitt, H.O. 1994: Delineation of the subunit composition of human proteasomes using antisera against the major histocompatibility complex-encoded LMP2 and LMP7 subunits. Proceedings of the National Academy of Sciences of the United States of America 91(1): 296-300

Hartong, R.; Wang, N.; Kurokawa, R.; Lazar, M.A.; Glass, C.K.; Apriletti, J.W.; Dillmann, W.H. 1994: Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ATPase gene. Demonstration that retinoid X receptor binds 5' to thyroid hormone receptor in response element 1. Journal of Biological Chemistry 269(17): 13021-13029

Rabelo, R.; Schifman, A.; Rubio, A.; Sheng, X.; Silva, J.E. 1995: Delineation of thyroid hormone-responsive sequences within a critical enhancer in the rat uncoupling protein gene. Endocrinology 136(3): 1003-1013

Orlowski, J.; Kandasamy, R.A. 1996: Delineation of transmembrane domains of the Na+/H+ exchanger that confer sensitivity to pharmacological antagonists. Journal of Biological Chemistry 271(33): 19922-19927

Quinn, A.G.; Sikkink, S.; Rees, J.L. 1994: Delineation of two distinct deleted regions on chromosome 9 in human non-melanoma skin cancers. Genes Chromosomes and Cancer 11(4): 222-225

Chamberlain, N.L.; Whitacre, D.C.; Miesfeld, R.L. 1996: Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. Journal of Biological Chemistry 271(43): 26772-26778

Smeltz, R.B.; Wolf, N.A.; Swanborg, R.H. 1998: Delineation of two encephalitogenic myelin basic protein epitopes for DA rats. Journal of Neuroimmunology 87(1-2): 43-48

Barberis, A.; Müller, C.W.; Harrison, S.C.; Ptashne, M. 1993: Delineation of two functional regions of transcription factor TFIIB. Proceedings of the National Academy of Sciences of the United States of America 90(12): 5628-5632

Nalefski, E.A.; Sultzman, L.A.; Martin, D.M.; Kriz, R.W.; Towler, P.S.; Knopf, J.L.; Clark, J.D. 1994: Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. Journal of Biological Chemistry 269(27): 18239-18249

Fairlie, W.D.; Stanton, P.G.; Hearn, M.T. 1995: Delineation of tyrosine-containing epitopes within the beta subunit of bovine thyrotropin. European Journal of Biochemistry 228(2): 373-380

Banton, O.; Lafrance, P.; Villeneuve, J.P. 1992: Delineation of well head protection area in agricultural zone by using solute transport modelling. Revue des Sciences de l'Eau 5(2): 211-227

Mcgarvey, E.L.; Canterbury, R.J.; Waite, D. 1996: Delinquency and family problems in incarcerated adolescents with and without a history of inhalant use. Addictive Behaviors 21(4): 537-542

Zerche, L. 1996: Deliphrosoma freudeorum spec. nov. from Eastern Turkey (Insecta: Coleoptera: Staphylinidae: Omaliinae). Reichenbachia 31(22-42): 175-177

van der Mast, R.C.; Roest, F.H. 1996: Delirium after cardiac surgery: A critical review. Journal of Psychosomatic Research 41(1): 13-30

Naughton, B.J.; Moran, M.B.; Kadah, H.; Heman-Ackah, Y.; Longano, J. 1995: Delirium and Other Cognitive Impairment in Older Adults in an Emergency Department. Annals of Emergency Medicine 25(6): 751-755

Kolbeinsson, H.; Jónsson, A. 1993: Delirium and dementia in acute medical admissions of elderly patients in Iceland. Acta Psychiatrica Scandinavica 87(2): 123-127

O'Keeffe, S.T.; Devlin, J.G. 1994: Delirium and the dexamethasone suppression test in the elderly. Neuropsychobiology 30(4): 153-156

Fukutani, Y.; Katsukawa, K.; Matsubara, R.; Kobayashi, K.; Nakamura, I.; Yamaguchi, N. 1993: Delirium associated with Joseph disease. Journal of Neurology Neurosurgery and Psychiatry 56(11): 1207-1212

Revankar, S.G.; Applegate, A.L.; Markovitz, D.M. 1995: Delirium associated with acyclovir treatment in a patient with renal failure. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 21(2): 435-436

Bonne, O.; Shalev, A.Y.; Bloch, M. 1995: Delirium associated with mianserin. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 5(2): 147-149

Barak, Y.; Levine, J.; Lampl, Y.; Elizur, A. 1995: Delirium during heroin withdrawal with doxepin: A short report. Human Psychopharmacology 10(2): 149-151

Baker, F.M.; Wiley, C.; Kokmen, E.; Chandra, V.; Schoenberg, B., S. 1995: Delirium during the course of clinically diagnosed Alzheimer's disease. International Journal of Geriatric Psychiatry 10(2): 93-97

Lerner, A.J.; Hedera, P.; Koss, E.; Stuckey, J.; Friedland, R.P. 1997: Delirium in Alzheimer disease. Alzheimer Disease and Associated Disorders 11(1): 16-20

Robertsson, B.; Blennow, K.; Gottfries, C.G.; Wallin, A. 1998: Delirium in dementia. International Journal of Geriatric Psychiatry 13(1): 49-56

Rummans, T.A.; Evans, J.M.; Krahn, L.E.; Fleming, K.C. 1995: Delirium in elderly patients: Evaluation and management. Mayo Clinic Proceedings 70(10): 989-998

Pompei, P.; Foreman, M.; Rudberg, M.A.; Inouye, S.K.; Braund, V.; Cassel, C.K. 1994: Delirium in hospitalized older persons: outcomes and predictors. Journal of the American Geriatrics Society 42(8): 809-815

Gomez-Mugica, G.; Marin-Lozano, J.J.; Graell-Berna, M.; Santodomingo-Carrasco, J. 1992: Delirium in the aged: Psychiatric perspective. Geriatrika 8(2): 29-32, 35-37

Sumner, A.D.; Simons, R.J. 1994: Delirium in the hospitalized elderly. Cleveland Clinic Journal of Medicine 61(4): 258-262

Weinrich, S.; Sarna, L. 1994: Delirium in the older person with cancer. Cancer 74(7 Suppl): 2079-2091

Pollak, P.T.; Sketris, I.S.; MacKenzie, S.L.; Hewlett, T.J. 1995: Delirium probably induced by clarithromycin in a patient receiving fluoxetine. Annals of PharmacoTherapy 29(5): 486-488

Elie, M.; Cole, M.G.; Primeau, F.J.; Bellavance, F. 1998: Delirium risk factors in elderly hospitalized patients. Journal of General Internal Medicine 13(3): 204-212

Gutierrez-Suela, F.; Rodriguez-Font, J.P. 1995: Delirium: Diagnosis, causes and management. Ciencia Pharmaceutica 5(3): 132-138

Wiedemann, G.; Hahlweg, K.; Hank, G.; Feinstein, E.; Müller, U.; Dose, M. 1994: Deliverability of psychoeducational family management. Schizophrenia Bulletin 20(3): 547-556

Abeni, D.D.; Porta, D.; Perucci, C.A. 1997: Deliveries, abortion and HIV-1 infection in Rome, 1989-1994. European Journal of Epidemiology 13(4): 373-378

Sixsmith, A.; Hawley, C.; Stilwell, J.; Copeland, J. 1993: Delivering positive care in nursing homes. International Journal of Geriatric Psychiatry 8(5): 407-412

Steffes, M.W.; Gillen, J.L.; Fuhrman, S.A. 1996: Delivering clinical laboratory services to intensive care units. Clinical Chemistry 42(3): 387-391

Solberg, L.I.; Kottke, T.E.; Conn, S.A.; Brekke, M.L.; Calomeni, C.A.; Conboy, K.S. 1997: Delivering clinical preventive services is a systems problem. Annals of Behavioral Medicine: a Publication of the Society of Behavioral Medicine 19(3): 271-278

Modell, B. 1997: Delivering genetic screening to the community. Annals of Medicine 29(6): 591-599,.

Partridge, M.R. 1995: Delivering optimal care to the person with asthma: what are the key components and what do we mean by patient education?. European Respiratory Journal 8(2): 298-305

Miyamoto, T.; Shimada, I.; Ueno, H. 1997: Delivering the right perfusate temperature at the right time. Japanese Journal of Artificial Organs 26(3): 820-825

Allahbadia, G.N.; Ambiye, V.R. 1992: Delivery after Shirodkar's abdominal sling operation. Journal of Obstetrics and Gynaecology 12(5): 294-296

Lai, S.F.; Sidek, S. 1993: Delivery after a lower segment caesarean section. Singapore Medical Journal 34(1): 62-66

Ashida, T.; Tsubaki, K.; Hazu, S.; Ishikawa, H.; Urase, F.; Horiuchi, A. 1996: Delivery after bone marrow transplantation with total lymphoid irradiation for severe aplastic anemia. International Journal of Hematology 64(3-4): 279-281

Kohlberger, P.T.H.lbich; Schaller, A. 1997: Delivery after resection of a maternal sacrococcygeal teratoma. Zeitschrift fur Geburtshilfe Neonatologie 201(4): 148-151

Boyce, S.T.; Holder, I.A.; Supp, A.P.; Warden, G.D.; Greenhalgh, D.G. 1994: Delivery and activity of antimicrobial drugs released from human fibrin sealant. Journal of Burn Care and Rehabilitation 15(3): 251-255

Tokui, T.; Takatori, T.; Shinozaki, N.; Ishigami, M.; Shiraishi, A.; Ikeda, T.; Tsuruo, T. 1995: Delivery and cytotoxicity of RS-1541 in St-4 human gastric cancer cells in vitro by the low-density-lipoprotein pathway. Cancer ChemoTherapy and Pharmacology 36(1): 1-6

O'Riordan, T.G.; Iacono, A.; Keenan, R.J.; Duncan, S.R.; Burckart, G.J.; Griffith, B.P.; Smaldone, G.C. 1995: Delivery and distribution of aerosolized cyclosporine in lung allograft recipients. American Journal of Respiratory and Critical Care Medicine 151(2 Part 1): 516-521

Layer, P.H.; Goebell, H.; Keller, J.; Dignass, A.; Klotz, U. 1995: Delivery and fate of oral mesalamine microgranules within the human small intestine. Gastroenterology 108(5): 1427-1433

Tetzschner, T.; Sørensen, M.; Jønsson, L.; Lose, G.; Christiansen, J. 1997: Delivery and pudendal nerve function. Acta Obstetricia Et Gynecologica Scandinavica 76(4): 324-331

Lewin, A.; Weiss, D.B.; Friedler, S.; Ben-Shachar, I.; Porat-Katz, A.; Meirow, D.; Schenker, J.G.; Safran, A. 1996: Delivery following intracytoplasmic injection of mature sperm cells recovered by testicular fine needle aspiration in a case of hypergonadotropic azoospermia due to maturation arrest. Human Reproduction 11(4): 769-771

Goffinet, F. 1997: Delivery hemorrhage: Management in France, and interest of prostaglandins. Journal de Gynecologie Obstetrique et biologie de la Reproduction 26(Suppl 2): 26-33

Bowman, J.G.; Sowell, B.F. 1997: Delivery method and supplement consumption by grazing ruminants: a review. Journal of Animal Science 75(2): 543-550

W.L., L.G.; Zhao Liping 1996: Delivery mode of growth retarded infant and results of perinatal infant. Xi'an Yike Daxue Xuebao 17(1): 100-102

Mandell, G.L. 1994: Delivery of antibiotics by phagocytes. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 19(5): 922-925

Drake, J.R.; Webster, P.; Cambier, J.C.; Mellman, I. 1997: Delivery of B cell receptor-internalized antigen to endosomes and class Ii vesicles. Journal of Experimental Medicine 186(8): 1299-1306

Bergersen, F.J. 1996: Delivery of O-2 to bacteroids in soybean nodule cells: Consideration of gradients of concentration of free, dissolved O-2 in and near symbiosomes and beneath intercellular spaces. Protoplasma 191(1-2): 9-20

Sells, M.A.; Li, J.; Chernoff, J. 1995: Delivery of protein into cells using polycationic liposomes. Biotechniques 19(1): 72

Lim, M.H.; Jeong, J.D.; Kim, I.S. 1994: Delivery of Ti plasmid into Nicotiana sanderae protoplasts via liposomes. Agricultural Chemistry and Biotechnology 37(5): 343-348

Levatte, M.A.; Weaver, L.C.; York, I.A.; Johnson, D.; Dekaban, G.A. 1995: Delivery of a foreign gene to sympathetic preganglionic neurons using recombinant herpes simplex virus. Neuroscience 66(3): 737-750

Kilpatrick, M.W.; Phylactou, L.A.; Godfrey, M.; Wu, C.H.; Wu, G.Y.; Tsipouras, P. 1996: Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblasts. Human Molecular Genetics 5(12): 1939-1944

Delgado Charro, M.B.; Iglesias Vilas, G.; Blanco Mendez, J.; Lopez Quintela, M.A.; Marty, J.P.; Guy, R.H. 1997: Delivery of a hydrophilic solute through the skin from novel microemulsion systems. European Journal of Pharmaceutics and Biopharmaceutics 43(1): 37-42

Ikonomidis, G.; Paterson, Y.; Kos, F.J.; Portnoy, D.A. 1994: Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes. Journal of Experimental Medicine 180(6): 2209-2218

Konopka, K.; Rossi, J.J.; Swiderski, P.; Slepushkin, V.A.; Düzgüneş, N. 1998: Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposomes. Biochimica Et Biophysica Acta 1372(1): 55-68

Tanigawa, K.; Hara, T.; Fujiwaki, R.; Kato, Y.; Kitao, M. 1995: Delivery of an infant with atresia of the ileum in a case of gestational diabetes. Journal of the Japan Diabetes Society 38(8): 637-641

Lu, D.; Raizada, M.K. 1995: Delivery of angiotensin II type 1 receptor antisense inhibits angiotensin action in neurons from hypertensive rat brain. Proceedings of the National Academy of Sciences of the United States of America 92(7): 2914-2918

Shea, T.B. 1994: Delivery of anti-GAP-43 antibodies into neuroblastoma cells reduces growth cone size. Biochemical and Biophysical Research Communications 203(1): 459-464

Vahrmeijer, A.L.; Van Der Eb, M.M.; Van Dierendonck, J.H.; Kuppen, P.J.; Van De Velde, C.J. 1998: Delivery of anticancer drugs via isolated hepatic perfusion: A promising strategy in the treatment of irresectable liver metastases?. Seminars in Surgical Oncology 14(3): 262-268

Goletz, T.J.; Klimpel, K.R.; Leppla, S.H.; Keith, J.M.; Berzofsky, J.A. 1997: Delivery of antigens to the MHC class I pathway using bacterial toxins. Human Immunology 54(2): 129-136

Urtti, A. 1994: Delivery of antiglaucoma drugs: ocular vs systemic absorption. Journal of Ocular Pharmacology 10(1): 349-357

Wang, S.; Lee, R.J.; Cauchon, G.; Gorenstein, D.G.; Low, P.S. 1995: Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proceedings of the National Academy of Sciences of the United States of America 92(8): 3318-3322

Ciftci, K.; Groves, M., J. 1996: Delivery of antitumor compounds to the rat colon: In vitro and in vivo evaluation. International Journal of Pharmaceutics (Amsterdam) 145(1-2): 157-164

Paul, T.R.; Knight, S.T.; Raulston, J.E.; Wyrick, P.B. 1997: Delivery of azithromycin to Chlamydia trachomatis-infected polarized human endometrial epithelial cells by polymorphonuclear leucocytes. Journal of Antimicrobial ChemoTherapy 39(5): 623-630

Baker, A.; Cotten, M. 1997: Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier. Nucleic Acids Research 25(10): 1950-1956

O'Callaghan, C.; Cant, M.; Robertson, C. 1994: Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation?. Thorax 49(10): 961-964

Allison, B.A.; Crespo, M.T.; Jain, A.K.; Richter, A.M.; Hsiang, Y.N.; Levy, J.G. 1997: Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits. Photochemistry and Photobiology 65(5): 877-883

Cherkauer, D., S.; Mckereghan, P., F.; Schalch, L., H. 1992: Delivery of chloride and nitrate by ground water to the Great Lakes: Case study for the Door Peninsula, Wisconsin. Ground Water 30(6): 885-894

Verma, N.K.; Ziegler, H.K.; Wilson, M.; Khan, M.; Safley, S.; Stocker, B.A.; Schoolnik, G.K. 1995: Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella. Vaccine 13(2): 142-150

Lew, T.W.; San, W.M.; Chin, M.K. 1993: Delivery of constant air-oxygen mixtures using a closed circle absorber system. Canadian Journal of Anaesthesia 40(4): 382-387

Kedar, E.; Rutkowski, Y.; Braun, E.; Emanuel, N.; Barenholz, Y. 1994: Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes. Journal of ImmunoTherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological Therapy 16(1): 47-59

Kedar, E.; Braun, E.; Rutkowski, Y.; Emanuel, N.; Barenholz, Y. 1994: Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in mice. Journal of ImmunoTherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological Therapy 16(2): 115-124

Kedar, E.; Palgi, O.; Golod, G.; Babai, I.; Barenholz, Y. 1997: Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice. Journal of ImmunoTherapy 20(3): 180-193

Wissmann, P.B.; Goodman, B.K.; Vockley, J.G.; Kern, R.M.; Cederbaum, S.D.; Grody, W.W. 1996: Delivery of cytosolic liver arginase into the mitochondrial matrix space: A possible novel site for gene replacement therapy. Somatic Cell and Molecular Genetics 22(6): 489-498

Casson, P.R.; Straughn, A.B.; Umstot, E.S.; Abraham, G.E.; Carson, S.A.; Buster, J.E. 1996: Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and nonoral administration. American Journal of Obstetrics and Gynecology 174(2): 649-653

Meskin, S.; Huyler, F.; Gupta, S.K.; Berger, L. 1997: Delivery of emergency medical services in Kathmandu, Nepal. Annals of Emergency Medicine 29(3): 409-414

Rüssmann, H.; Shams, H.; Poblete, F.; Fu, Y.; Galán, J.E.; Donis, R.O. 1998: Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281(5376): 565-568

Li, Y.; Ke, Y.; Gottlieb, P.D.; Kapp, J.A. 1994: Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation. Journal of Leukocyte Biology 56(5): 616-624

Leflein, J.; Brown, E.; Hill, M.; Kelly, H.W.; Loffert, D.T.; Nelson, H.S.; Szefler, S.J. 1995: Delivery of glucocorticoids by jet nebulization: Aerosol characteristics and output. Journal of Allergy and Clinical Immunology 95(5 Pt 1): 944-949

Wilson, N.; Dovey, S.; Bandaranayake, D.; Tilyard, M. 1995: Delivery of hepatitis B immunisations in a selection of computerised general practices. New Zealand Medical Journal 108(993): 34-36

Nilaver, G.; Muldoon, L.L.; Kroll, R.A.; Pagel, M.A.; Breakefield, X.O.; Davidson, B.L.; Neuwelt, E.A. 1995: Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proceedings of the National Academy of Sciences of the United States of America 92(21): 9829-9833

Hortelano, G.; Al-Hendy, A.; Ofosu, F.A.; Chang, P.L. 1996: Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood 87(12): 5095-5103

Johnston, P.; Nam, M.; Hossain, M.A.; Indurti, R.R.; Mankowski, J.L.; Wilson, M.A.; Laterra, J. 1996: Delivery of human fibroblast growth factor-1 gene to brain by modified rat brain endothelial cells. Journal of Neurochemistry 67(4): 1643-1652

Stoeckle, M.Y.; Falck-Pederson, E.; Rubin, B.Y.; Anderson, S.L.; Murray, H.W. 1996: Delivery of human interferon-gamma via gene transfer in vitro: prolonged expression and induction of macrophage antimicrobial activity. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 16(12): 1015-1019

Kim, M.K.; Chung, S.J.; Lee, M.H.; Shim, C.K. 1998: Delivery of hydrocortisone from liposomal suspensions to the hairless mouse skin following topical application under non-occlusive and occlusive conditions. Journal of Microencapsulation 15(1): 21-29

Kirmse, M.; Hess, D.; Fujino, Y.; Kacmarek, R.M.; Hurford, W.E. 1998: Delivery of inhaled nitric oxide using the Ohmeda INOvent Delivery System. Chest 113(6): 1650-1657

Killion, J.J.; Fishbeck, R.; Bar-Eli, M.; Chernajovsky, Y. 1994: Delivery of interferon to intracellular pathways by encapsulation of interferon into multilamellar liposomes is independent of the status of interferon receptors. Cytokine 6(4): 443-449

Kaplan, D.R. 1994: Delivery of interleukin 2 for immunotherapy. Journal of Chromatography. B Biomedical Applications 662(2): 315-323

Ansari, N.H.; He, Q.; Cook, J.D.; Wen, J.; Srivastava, S.K. 1997: Delivery of liposome-sequestered hydrophobic proteins to lysosomes of normal and Batten disease cells. Journal of Neuroscience Research 47(3): 341-347

Alyautdin, R.N.; Petrov, V.E.; Langer, K.; Berthold, A.; Kharkevich, D.A.; Kreuter, J. 1997: Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharmaceutical Research 14(3): 325-328

Akamo, Y.; Yotsuyanagi, T.; Mizuno, I.; Ichino, T.; Tanimoto, N.; Kurahashi, S.; Saito, T.; Yamamoto, T.; Yasui, T.; Itabashi, Y. 1993: Delivery of lymph node-targeted adriamycin by gastric submucosal liposomal injection in rabbits. Japanese Journal of Cancer Research: Gann 84(2): 208-213

Bright, G.R.; Kuo, N.T.; Chow, D.; Burden, S.; Dowe, C.; Przybylski, R.J. 1996: Delivery of macromolecules into adherent cells via electroporation for use in fluorescence spectroscopic imaging and metabolic studies. Cytometry 24(3): 226-233

Lee, K.D.; Oh, Y.K.; Portnoy, D.A.; Swanson, J.A. 1996: Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. Journal of Biological Chemistry 271(13): 7249-7252

Zhao, L.; Hung, L.K.; Choy, T.T. 1997: Delivery of medication by iontophoresis to treat post-burn hypertrophic scars: investigation of a new electronic technique. Burns: Journal of the International Society for Burn Injuries 23(Suppl): S27-S29

Barber, K.; Mala, R.R.; Lambert, M.P.; Qiu, R.; Macdonald, R.C.; Klein, W.L. 1996: Delivery of membrane-impermeant fluorescent probes into living neural cell populations by lipotransfer. Neuroscience Letters 207(1): 17-20

Fok, T.F.; al-Essa, M.; Monkman, S.; Dolovich, M.; Girard, L.; Coates, G.; Kirpalani, H. 1997: Delivery of metered dose inhaler aerosols to paralyzed and nonparalyzed rabbits. Critical Care Medicine 25(1): 140-144

Jain, R.K. 1998: Delivery of molecular and cellular medicine to solid tumors. Journal of Controlled Release: Official Journal of the Controlled Release Society 53(1-3): 49-67

Jain, R.K. 1997: Delivery of molecular and cellular medicine to solid tumors. Advanced Drug Delivery Reviews 26(2-3): 71-90

De Ascentiis, A.; Bettini, R.; Caponetti, G.; Catellani, P.L.; Peracchia, M.T.; Santi, P.; Colombo, P. 1996: Delivery of nasal powders of beta-cyclodextrin by insufflation. Pharmaceutical Research 13(5): 734-738

Morton, P.A.; Zacheis, M.L.; Giacoletto, K.S.; Manning, J.A.; Schwartz, B.D. 1995: Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. Journal of Immunology 154(1): 137-150

Coupaye-Gerard, B.; Zuckerman, J.B.; Duncan, P.; Bortnik, A.; Avery, D.I.; Ernst, S.A.; Kleyman, T.R. 1997: Delivery of newly synthesized Na(+)-K(+)-ATPase to the plasma membrane of A6 epithelia. American Journal of Physiology 272(6 Part 1): C1781-C1789

Blanck, Z.; Biehl, M.; Sra, J.; Dhala, A.; Akhtar, M. 1997: Delivery of noncommitted shocks for nonsustained ventricular arrhythmias by a new implantable cardioverter defibrillator with abortive shock capability. Journal of Cardiovascular Electrophysiology 8(3): 317-322

Takle, G.B.; Thierry, A.R.; Flynn, S.M.; Peng, B.; White, L.; Devonish, W.; Galbraith, R.A.; Goldberg, A.R.; George, S.T. 1997: Delivery of oligoribonucleotides to human hepatoma cells using cationic lipid particles conjugated to ferric protoporphyrin IX (heme). Antisense and Nucleic Acid Drug Development 7(3): 177-185

Legendre, J.Y.; Szoka, F.C. 1992: Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: Comparison with cationic liposomes. Pharmaceutical Research 9(10): 1235-1242

Takakura, Y.; Hashida, M. 1996: Delivery of plasmid DNA to endothelial cells. European Journal of Pharmaceutics and Biopharmaceutics 42(4): 269-276

Holmberg, E.G.; Reuer, Q.R.; Geisert, E.E.; Owens, J.L. 1994: Delivery of plasmid DNA to glial cells using pH-sensitive immunoliposomes. Biochemical and Biophysical Research Communications 201(2): 888-893

Schulsinger, C.; Mednick, B.R.; Klebanoff, M.A.; Secher, N.J.; Teasdale, T.W.; Baker, R.L. 1993: Delivery of preterm and small for gestational age infants across generations. Acta Psychiatrica Scandinavica. Supplementum 370: 62-66

Gans, B.M.; Mann, N.R.; Becker, B.E. 1993: Delivery of primary care to the physically challenged. Archives of Physical Medicine and Rehabilitation 74(12 Spec No): S15-S19

Tulman, E.R.; Garmendia, A.E. 1994: Delivery of pseudorabies virus envelope antigens enclosed in immunostimulating complexes (ISCOMs); elicitation of neutralizing antibody and lymphoproliferative responses in swine and protection in mice. Vaccine 12(14): 1349-1354

Scheule, R.K.; Bagley, R.G.; Erickson, A.L.; Wang, K.X.; Fang, S.L.; Vaccaro, C.; O'Riordan, C.R.; Cheng, S.H.; Smith, A.E. 1995: Delivery of purified, functional CFTR to epithelial cells in vitro using influenza hemagglutinin. American Journal of Respiratory Cell and Molecular Biology 13(3): 330-343

Hawkins, G.A.; McCabe, R.P.; Kim, C.H.; Subramanian, R.; Bredehorst, R.; McCullers, G.A.; Vogel, C.W.; Hanna, M.G.; Pomato, N. 1993: Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system. Cancer Research 53(10 Suppl): 2368-2373

Peirone, M.A.; Delaney, K.; Kwiecin, J.; Fletch, A.; Chang, P.L. 1998: Delivery of recombinant gene product to canines with nonautologous microencapsulated cells. Human Gene Therapy 9(2): 195-206

Figueiredo, D.M.; Hallewell, R.A.; Chen, L.L.; Fairweather, N.F.; Dougan, G.; Savitt, J.M.; Parks, D.A.; Fishman, P.S. 1997: Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous system neurons by retrograde axonal transport. Experimental Neurology 145(2 Part 1): 546-554

Clarke, J.R.; Aston, H.; Silverman, M. 1993: Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Archives of Disease in Childhood 69(1): 125-129

Fok, T.F.; Lam, K.; Ng, P.C.; Leung, T.F.; So, H.K.; Cheung, K.L.; Wong, W. 1998: Delivery of salbutamol to nonventilated preterm infants by metered-dose inhaler, jet nebulizer, and ultrasonic nebulizer. European Respiratory Journal 12(1): 159-164

Bonardi, M.A.; French, R.R.; Amlot, P.; Gromo, G.; Modena, D.; Glennie, M.J. 1993: Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing. Cancer Research 53(13): 3015-3021

Briscoe, P.; Caniggia, I.; Graves, A.; Benson, B.; Huang, L.; Tanswell, A.K.; Freeman, B.A. 1995: Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. American Journal of Physiology 268(3 Pt 1): L374-L380

Morgan, R.V. 1995: Delivery of systemic regular insulin via the ocular route in cats. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 11(4): 565-573

Anderson, R.; Dougan, G.; Roberts, M. 1996: Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response. Vaccine 14(14): 1384-1390

Kadurugamuwa, J.L.; Beveridge, T.J. 1998: Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles. Antimicrobial Agents and ChemoTherapy 42(6): 1476-1483

Chauhan, S.P.; Roberts, W.E.; McLaren, R.A.; Roach, H.; Morrison, J.C.; Martin, J.N. 1995: Delivery of the nonvertex second twin: breech extraction versus external cephalic version. American Journal of Obstetrics and Gynecology 173(4): 1015-1020

Nguyen, D.M.; Wiehle, S.A.; Koch, P.E.; Branch, C.; Yen, N.; Roth, J.A.; Cristiano, R.J. 1997: Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Cancer Gene Therapy 4(3): 191-198

Gentschev, I.; Glaser, I.; Goebel, W.; McKeever, D.J.; Musoke, A.; Heussler, V.T. 1998: Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle. Infection and Immunity 66(5): 2060-2064

Gilady, Y.; Battino, S.; Reich, D.; Gilad, G.; Shalev, E. 1996: Delivery of the very low birthweight breech: what is the best way for the baby?. Israel Journal of Medical Sciences 32(2): 116-120

Kuster, P.; Taravella, M.; Gelinas, M.; Stepp, P. 1998: Delivery of trifluridine to human cornea and aqueous using collagen shields. Clao Journal: Official Publication of the Contact Lens Association of Ophthalmologists Inc 24(2): 122-124

Thomas, S.H.; O'Doherty, M.J.; Page, C.J.; Treacher, D.F.; Nunan, T.O. 1993: Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. American Review of Respiratory Disease 148(4 Part 1): 872-877

Dommergues, M.; Mahieu-Caputo, D.; Mandelbrot, L.; Huon, C.; Moriette, G.; Dumez, Y. 1995: Delivery of uncomplicated triplet pregnancies: is the vaginal route safer? A case-control study. American Journal of Obstetrics and Gynecology 172(2 Pt 1): 513-517

Neuwelt, E.A.; Weissleder, R.; Nilaver, G.; Kroll, R.A.; Roman-Goldstein, S.; Szumowski, J.; Pagel, M.A.; Jones, R.S.; Remsen, L.G.; McCormick, C.I. 1994: Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 34(4): 777-784

Uyama, S.; Kaufmann, P.M.; Takeda, T.; Vacanti, J.P. 1993: Delivery of whole liver-equivalent hepatocyte mass using polymer devices and hepatotrophic stimulation. Transplantation 55(4): 932-935

Källén, B. 1998: Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. British Journal of Obstetrics and Gynaecology 105(8): 877-881

Källén, B.; Landgren, O. 1994: Delivery outcome in pregnancies when either parent worked in the chemical industry. A study with central registries. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 36(5): 563-568

Coughlin, J.P.; Drucker, D.E.; Jewell, M.R.; Evans, M.J.; Klein, M.D. 1993: Delivery room repair of gastroschisis. Surgery 114(4): 822

Doron, M.W.; Veness-Meehan, K.A.; Margolis, L.H.; Holoman, E.M.; Stiles, A.D. 1998: Delivery room resuscitation decisions for extremely premature infants. Pediatrics 102(3 Pt 1): 574-582

Muranishi, S. 1997: Delivery system design for improvement of intestinal absorption of peptide drugs. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 117(7): 394-414

Velin, D.; Hopkins, S.; Kraehenbuhl, J. 1998: Delivery systems and adjuvants for vaccination against HIV. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 66(3-4): 170-175

Waelti, E.R.; Glück, R. 1998: Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes). International Journal of Cancer 77(5): 728-733

van Deurs, B.; Holm, P.K.; Kayser, L.; Sandvig, K. 1995: Delivery to lysosomes in the human carcinoma cell line HEp-2 involves an actin filament-facilitated fusion between mature endosomes and preexisting lysosomes. European Journal of Cell Biology 66(4): 309-323

Guion Almeida, M.L.; Kokitsu Nakata, N.M. 1996: Delleman syndrome in a Brazilian boy. Brazilian Journal of Genetics 19(4): 625-627

Sadhasivam, S.; Subramaniam, R. 1998: Delleman syndrome: anesthetic implications. Anesthesia and Analgesia 87(3): 553-555

Freitas-Fernandes, L.B.; Rundegren, J.; Arnebrant, T.; Glantz, P.O. 1998: Delmopinol hydrochloride- and chlorhexidine digluconate-induced precipitation of salivary proteins of different molecular weights. Acta Odontologica Scandinavica 56(1): 2-8

Rundegren, J.; Sjödin, T.; Petersson, L.; Hansson, E.; Jonsson, I. 1995: Delmopinol interactions with cell walls of gram-negative and gram-positive oral bacteria. Oral Microbiology and Immunology 10(2): 102-109

Kloc, M.; Etkin, L.D. 1994: Delocalization of Vg1 mRNA from the vegetal cortex in Xenopus oocytes after destruction of Xlsirt RNA. Science 265(5175): 1101-1103

Rivera-León, R.; Gerbi, S.A. 1997: Delocalization of some small nucleolar RNPs after actinomycin D treatment to deplete early pre-rRNAs. Chromosoma 105(7-8): 506-514

Willett, W.S.; Brinen, L.S.; Fletterick, R.J.; Craik, C.S. 1996: Delocalizing trypsin specificity with metal activation. Biochemistry 35(19): 5992-5998

Goh, T.K.; Hyde, K.D. 1997: Delortia palmicola and two new species from wood submerged in a freshwater stream in Australia. Mycological Research 101(1): 42-46

Whitehill, W.R.; Wright, K.E. 1994: Delphi Study: HIV/AIDS and the Athletic Population. Journal of Athletic Training 29(2): 114-119

Gale, R.P.; Park, R.E.; Dubois, R.W.; Herzig, G.P.; Hocking, W.G.; Horowitz, M.M.; Keating, A.; Kempin, S.; Linker, C.A.; Schiffer, C.A.; Wiernik, P.H.; Weisdorf, D.J.; Rai, K.R. 1998: Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. Leukemia Research 22(11): 973-981

Ramstad, B.; Pedersen, A.T.; Andersen, O.M. 1995: Delphinidin 3-alpha-arabinopyranoside and other anthocyanins from flowers of Rhododendron cv. Lems Stormcloud. Journal of Horticultural Science 70(4): 637-642

Kukel, C.F.; Jennings, K.R. 1994: Delphinium alkaloids as inhibitors of alpha-bungarotoxin binding to rat and insect neural membranes. Canadian Journal of Physiology and Pharmacology 72(1): 104-107

Ktonas, P.Y.; Fagioli, I.; Salzarulo, P. 1995: Delta (0.5-1.5 HZ) and sigma (11.5-15.5 Hz) EEG power dynamics throughout quiet sleep in infants. Electroencephalography and Clinical Neurophysiology 95(2): 90-96

Cai, Y.; Zhang, Y.; Wu, Y.; Pei, G. 1996: delta Opioid receptor in neuronal cells undergoes acute and homologous desensitization. Biochemical and Biophysical Research Communications 219(2): 342-347

Miyamae, T.; Fukushima, N.; Misu, Y.; Ueda, H. 1993: Delta opioid receptor mediates phospholipase C activation via Gi in Xenopus oocytes. Febs Letters 333(3): 311-314

Salvadori, S.; Attila, M.; Balboni, G.; Bianchi, C.; Bryant, S.D.; Crescenzi, O.; Guerrini, R.; Picone, D.; Tancredi, T.; Temussi, P.A. 1995: Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Molecular Medicine 1(6): 678-689

Doner, L., W.; Brause, A., R.; Petrus, D., R. 1992: Delta Oxygen-18 measurements in water for detection of sugar beet-derived syrups in frozen concentrated orange juice: Collaborative study. Journal - Association of Official Analytical Chemists 75(6): 1107-1111

Vgontzas, A.N.; Friedman, T.C.; Chrousos, G.P.; Bixler, E.O.; Vela-Bueno, A.; Kales, A. 1995: Delta Sleep-Inducing Peptide in Normal Humans and in Patients With Sleep Apnea and Narcolepsy. Peptides 16(6): 1153-1156

Zhu, W.J.; Wang, J.F.; Krueger, K.E.; Vicini, S. 1996: Delta subunit inhibits neurosteroid modulation of GABAA receptors. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(21): 6648-6656

Zeng, C.; Younger-Shepherd, S.; Jan, L.Y.; Jan, Y.N. 1998: Delta and Serrate are redundant Notch ligands required for asymmetric cell divisions within the Drosophila sensory organ lineage. Genes and Development 12(8): 1086-1091

Yu, W.Z.; Ruegg, H.; Bodnar, R.J. 1997: Delta and kappa opioid receptor subtypes and ingestion: Antagonist and glucoprivic effects. Pharmacology Biochemistry and Behavior 56(3): 353-361

Chu, P.; Murray, S.; Lissin, D.; von Zastrow, M. 1997: Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. Journal of Biological Chemistry 272(43): 27124-27130

Hanke, J.; Willig, A.; Yinon, U.; Jaros, P.P. 1997: Delta and kappa opioid receptors in eyestalk ganglia of a crustacean. Brain Research 744(2): 279-284

Lupica, C.R. 1995: Delta and mu enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(1 Part 2): 737-749

Amzica, F.; Nuñez, A.; Steriade, M. 1992: Delta frequency (1-4 Hz) oscillations of perigeniculate thalamic neurons and their modulation by light. Neuroscience 51(2): 285-294

Parks, A.L.; Muskavitch, M.A. 1993: Delta function is required for bristle organ determination and morphogenesis in Drosophila. Developmental Biology 157(2): 484-496

Makhmudov, O.S.; Inoyatova, F.I.; Kadirov, B.A.; Abdumadjidova, S.U. 1997: Delta infection in children with chronic viral hepatitis B. Turkish Journal of Pediatrics 39(1): 75-80

Doherty, D.; Feger, G.; Younger-Shepherd, S.; Jan, L.Y.; Jan, Y.N. 1996: Delta is a ventral to dorsal signal complementary to Serrate, another Notch ligand, in Drosophila wing formation. Genes and Development 10(4): 421-434

Portoghese, P.S.; Sultana, M.; Nelson, W.L.; Klein, P.; Takemori, A.E. 1992: Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: Evidence for delta receptor subtypes. Journal of Medicinal Chemistry 35(22): 4086-4091

Wu, G.; Zhang, F.; Salley, R.K.; Diana, J.N.; Su, T.P.; Chien, S. 1996: Delta opioid extends hypothermic preservation time of the lung. Journal of Thoracic and Cardiovascular Surgery 111(1): 259-267

He, L.; Lee, N.M. 1998: Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. Journal of Pharmacology and Experimental Therapeutics 285(3): 1181-1186

Chuang, L.F.; Chuang, T.K.; Killam, K.F.; Chuang, A.J.; Kung, H.F.; Yu, L.; Chuang, R.Y. 1994: Delta opioid receptor gene expression in lymphocytes. Biochemical and Biophysical Research Communications 202(3): 1291-1299

Mansour, A.; Thompson, R.C.; Akil, H.; Watson, S.J. 1993: Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA. Journal of Chemical Neuroanatomy 6(6): 351-362

Misicka, A.; Lipkowski, A.W.; Horvath, R.; Davis, P.; Porreca, F.; Yamamura, H.I.; Hruby, V.J. 1994: Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analogues. International Journal of Peptide and Protein Research 44(6): 607

Sánchez-Blázquez, P.; Garzón, J. 1998: Delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. Journal of Pharmacology and Experimental Therapeutics 285(2): 820-827

Haney, M.; Miczek, K.A. 1995: Delta opioid receptors: reflexive, defensive and vocal affective responses in female rats. Psychopharmacology 121(2): 204-212

Cutler, R.E.; Maizels, E.T.; Hunzicker-Dunn, M. 1994: Delta protein kinase-C in the rat ovary: estrogen regulation and localization. Endocrinology 135(4): 1669-1678

Roelants, F.; Potier, S.; Souciet, J.L.; de Montigny, J. 1997: Delta sequence of Ty1 transposon can initiate transcription of the distal part of the URA2 gene complex in Saccharomyces cerevisiae. Fems Microbiology Letters 148(1): 69-74

Keshavan, M.S.; Reynolds, C.F.; Miewald, M.J.; Montrose, D.M.; Sweeney, J.A.; Vasko, R.C.; Kupfer, D.J. 1998: Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data. Archives of General Psychiatry 55(5): 443-448

Giusti, M.; Carraro, A.; Porcella, E.; Valenti, S.; Nicora, D.; Sessarego, P.; Giordano, G. 1993: Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women. Psychoneuroendocrinology 18(1): 79-84

van Kammen, D.P.; Widerlöv, E.; Neylan, T.C.; Ekman, R.; Kelley, M.E.; Mouton, A.; Peters, J.L. 1992: Delta sleep-inducing-peptide-like immunoreactivity (DSIP-LI) and delta sleep in schizophrenic volunteers. Sleep 15(6): 519-525

Connor, M.; Henderson, G. 1996: delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. British Journal of Pharmacology 117(2): 333-340

Cosson, P.; Démollière, C.; Hennecke, S.; Duden, R.; Letourneur, F. 1996: Delta- and zeta-COP, two coatomer subunits homologous to clathrin-associated proteins, are involved in ER retrieval. EMBO Journal 15(8): 1792-1798

Ahmad, I.; Dooley, C.M.; Polk, D.L. 1997: Delta-1 is a regulator of neurogenesis in the vertebrate retina. Developmental Biology 185(1): 92-103

Mayfield, K.P.; D'Alecy, L.G. 1994: Delta-1 opioid agonist acutely increases hypoxic tolerance. Journal of Pharmacology and Experimental Therapeutics 268(2): 683-688

Mayfield, K.P.; D'Alecy, L.G. 1994: Delta-1 opioid receptor dependence of acute hypoxic adaptation. Journal of Pharmacology and Experimental Therapeutics 268(1): 74-77

Vernet, J.-Louis; Pachiaudi, C.; Bazile, F.; Durand, A.; Fabre, L.; Heinz, C.; Solari, M.-Eugenie; Thiebault, S. 1996: Delta-13C change based on Mediterranean prehistoric and historic charcoal from 35,000 BP to present. First results. Comptes Rendus de l'Academie des Sciences Serie II A Sciences de la Terre et des Planetes 323(4): 319-324

France, R., L.; Holmquist, J., G. 1997: Delta-13C variability of microalgae: Effects of water motion via baffling by seagrasses and mangroves. Marine Ecology Progress Series 149(1-3): 305-308

Handley, L.L.; Odee, D.; Scrimgeour, C.M. 1994: Delta-15N and delta-13C patterns in savanna vegetation: Dependence on water availability and disturbance. Functional Ecology 8(3): 306-314

Voss, M.; Altabet, M.A.; Bodungen, B.V. 1996: Delta-15N in sedimenting particles as indicator of euphotic-zone processes. Deep-Sea Research Part I Oceanographic Research Papers 43(1): 33-47

Saurer, M.; Borella, S.; Leuenberger, M. 1997: Delta-18O of tree rings of beech (Fagus silvatica) as a record of delta-18O of the growing season precipitation. Tellus Series B Chemical and Physical Meteorology 49(1): 80-92

Van-Donkelaar, C.; Hutcheon, I.E.; Krouse, H.R. 1995: Delta-34S, delta-18O, delta-D in shallow groundwater: Tracing anthropogenic sulfate and accompanying groundwater/rock interactions. Water Air and Soil Pollution 79(1-4): 279-298

Dikkeschei, L.D.; Willemse, P.H.; Wolthers, B.G.; de Ruyter-Buitenhuis, A.W.; Nagel, G.T. 1993: Delta-5-androstenediol and its sulphate in serum and urine of normal adults and patients with endocrine diseases. Clinical Endocrinology 39(4): 475-482

Melin, T.; Nilsson, A. 1997: Delta-6-desaturase and delta-5-desaturase in human Hep G2 cells are both fatty acid interconversion rate limiting and are upregulated under essential fatty acid deficient conditions. Prostaglandins Leukotrienes and Essential Fatty Acids 56(6): 437-442

Itoh, R.; Toda, K.; Takahashi, H.; Takano, H.; Kuroiwa, T. 1998: Delta-9 fatty acid desaturase gene containing a carboxyl-terminal cytochrome b5 domain from the red alga Cyanidioschyzon merolae. Current Genetics 33(3): 165-170

Bonnin, A.; Fernández-Ruiz, J.J.; Martín, M.; Rodríguez de Fonseca, F.; Hernández, M.L.; Ramos, J.A. 1993: Delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens. Journal of Neural Transmission. General Section 92(2-3): 81-95

Ghosh, S.K.; Poddar, M.K. 1993: Delta-9-Tetrahydrocannabinol inhibits the binding of theophylline to mammalian neuronal and non-neuronal membranes. Biochemical Pharmacology 45(8): 1725-1728

Mailleux, P.; Vanderhaeghen, J.J. 1994: delta-9-Tetrahydrocannabinol regulates substance P and enkephalin mRNAs levels in the caudate-putamen. European Journal of Pharmacology 267(1): R1-R3

Zhu, W.; Igarashi, T.; Qi, Z.T.; Newton, C.; Widen, R.E.; Friedman, H.; Klein, T.W. 1993: delta-9-Tetrahydrocannabinol (THC) decreases the number of high and intermediate affinity IL-2 receptors of the IL-2 dependent cell line NKB61A2. International Journal of Immunopharmacology 15(3): 401-408

Graceffo, T.J.; Robinson, J.K. 1998: Delta-9-tetrahydrocannabinol (THC) fails to stimulate consumption of a highly palatable food in the rat. Life Sciences 62(8): PL85-PL88

Murphy, L., L.; Chandrashekar, V.; Bartke, A. 1994: Delta-9-tetrahydrocannabinol inhibits pulsatile luteinizing hormone secretion in the male rat: Effect of intracerebroventricular norepinephrine infusion. Neuroendocrinology Letters 16(1): 1-8

Zheng, Z.M.; Specter, S.C. 1996: Delta-9-tetrahydrocannabinol suppresses tumor necrosis factor alpha maturation and secretion but not its transcription in mouse macrophages. International Journal of Immunopharmacology 18(1): 53-68

Trisler, K.; Specter, S. 1994: Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes. International Journal of Immunopharmacology 16(7): 593-603

Tang, J.L.; Lancz, G.; Specter, S. 1993: Delta-9-tetrahydrocannabinol-(THC)-mediated inhibition of macrophage macromolecular metabolism is antagonized by human serum proteins and by cell surface proteins. International Journal of Immunopharmacology 15(6): 665-672

Lipson, D.A.; Raab, T.K.; Monson, R.K. 1996: Delta-Acetylornithine as a major nitrogen storage compound in Bistorta bistortoides. Phytochemistry 41(1): 29-30

Takahashi, M.; McCurdy, D.T.; Essig, D.A.; Hood, D.A. 1993: Delta-Aminolaevulinate synthase expression in muscle after contractions and recovery. Biochemical Journal 291: 219-223

Chalevelakis, G.; Bouronikou, H.; Yalouris, A.G.; Economopoulos, T.; Athanaselis, S.; Raptis, S. 1995: Delta-Aminolaevulinic acid dehydratase as an index of lead toxicity. Time for a reappraisal?. European journal of clinical investigation 25(1): 53-58

Kery, V.; Elleder, D.; Kraus, J.P. 1995: Delta-aminolevulinate increases heme saturation and yield of human cystathionine beta-synthase expressed in Escherichia coli. Archives of Biochemistry and Biophysics 316(1): 24-29

Rodrigues, A.L.; Rocha, J.B.; Pereira, M.E.; Souza, D.O. 1996: Delta-aminolevulinic acid dehydratase activity in weanling and adult rats exposed to lead acetate. Bulletin of Environmental Contamination and Toxicology 57(1): 47-53

Schwartz, B.S.; Lee, B.K.; Stewart, W.; Sithisarankul, P.; Strickland, P.T.; Ahn, K.D.; Kelsey, K. 1997: delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occupational and Environmental Medicine 54(4): 241-246

Afonso, S.G.; Chinarro, S.; Enriquez de Salamanca, R.; Batlle, A.M. 1994: delta-Aminolevulinic acid dehydratase inactivation by uroporphyrin I in light and darkness. International Journal of Biochemistry 26(2): 255-258

Wyss, P.A.; Carter, B.E.; Roth, K.S. 1992: delta-Aminolevulinic acid dehydratase: effects of succinylacetone in rat liver and kidney in an in vivo model of the renal Fanconi syndrome. Biochemical Medicine and Metabolic Biology 48(1): 86-89

Helson, L.; Braverman, S.; Mangiardi, J. 1993: delta-Aminolevulinic acid effects on neuronal and glial tumor cell lines. Neurochemical Research 18(12): 1255-1258

Sakai, T.; Morita, Y. 1996: Delta-Aminolevulinic acid in plasma or whole blood as a sensitive indicator of lead effects, and its relation to the other heme-related parameters. International Archives of Occupational and Environmental Health 68(2): 126-132

Cubeddu, R.; Canti, G.; Taroni, P.; Valentini, G. 1995: delta-Aminolevulinic acid induced fluorescence in tumour-bearing mice. Journal of Photochemistry and Photobiology. B Biology 30(1): 23-27

Bermúdez Moretti, M.; Correa García, S.; Stella, C.; Ramos, E.; Batlle, A.M. 1993: Delta-aminolevulinic acid transport in Saccharomyces cerevisiae. International Journal of Biochemistry 25(12): 1917-1924

Bermúdez Moretti, M.; Correa García, S.; Ramos, E.; Batlle, A. 1996: delta-Aminolevulinic acid uptake is mediated by the gamma-aminobutyric acid-specific permease UGA4. Cellular and Molecular Biology 42(4): 519-523

Penatti, C.A.; Bechara, E.J.; Demasi, M. 1996: delta-Aminolevulinic acid-induced synaptosomal Ca2+ uptake and mitochondrial permeabilization. Archives of Biochemistry and Biophysics 335(1): 53-60

Latham, K.A.; Lloyd, R.S. 1995: Delta-Elimination by T4 endonuclease V at a thymine dimer site requires a secondary binding event and amino acid Glu-23. Biochemistry 34(27): 8796-8803

Rossa, C.; Mignone, C. 1993: Delta-Endotoxin activity and spore production in batch and fed-batch cultures of Bacillus thuringiensis. Biotechnology letters 15(3): 295-300

Lorence, A.; Darszon, A.; Díaz, C.; Liévano, A.; Quintero, R.; Bravo, A. 1995: Delta-endotoxins induce cation channels in Spodoptera frugiperda brush border membranes in suspension and in planar lipid bilayers. Febs Letters 360(3): 217-222

Zhao, H.M.; Wenthold, R.J.; Wang, Y.X.; Petralia, R.S. 1997: Delta-glutamate receptors are differentially distributed at parallel and climbing fiber synapses on Purkinje cells. Journal of Neurochemistry 68(3): 1041-1052

Shiau, C.Y.; Baldwin, J.E.; Byford, M.F.; Schofield, C.J. 1995: Delta-L-(alpha-aminoadipoyl)-L-cysteinyl-D-valine synthetase: isolation of L-cysteinyl-D-valine, a 'shunt' product, and implications for the order of peptide bond formation. Febs Letters 373(3): 303-306

Shiau, C.Y.; Baldwin, J.E.; Byford, M.F.; Sobey, W.J.; Schofield, C.J. 1995: delta-L-(alpha-aminoadipoyl)-L-cysteinyl-D-valine synthetase: the order of peptide bond formation and timing of the epimerisation reaction. Febs Letters 358(1): 97-100

Muskavitch, M.A. 1994: Delta-notch signaling and Drosophila cell fate choice. Developmental Biology 166(2): 415-430

Law, P.Y.; Loh, H.H. 1993: delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells. Molecular Pharmacology 43(5): 684-693

Chamouard, P.; Rohr, S.; Meyer, C.; Baumann, R.; Angel, F. 1994: Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon. European Journal of Pharmacology 262(1-2): 33-39

Jones, D.N.; Bowen, W.D.; Portoghese, P.S.; Holtzman, S.G. 1993: Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. European Journal of Pharmacology 249(2): 167-177

Arvidsson, U.; Dado, R.J.; Riedl, M.; Lee, J.H.; Law, P.Y.; Loh, H.H.; Elde, R.; Wessendorf, M.W. 1995: delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(2): 1215-1235

Connor, M.A.; Keir, M.J.; Henderson, G. 1997: delta-opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: lack of evidence for delta-receptor subtypes. Neuropharmacology 36(1): 125-133

Kamei, J.; Hitosugi, H.; Misawa, M.; Nagase, H.; Kasuya, Y. 1993: Delta-opiod receptor-mediated forced swimming stress-induced antinociception in the formalin test. Psychopharmacology 113(1): 15-18

Manzanares, J.; Durham, R.A.; Lookingland, K.J.; Moore, K.E. 1993: delta-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat. European Journal of Pharmacology 249(1): 107-112

Li, X.; Varga, E.V.; Stropova, D.; Zalewska, T.; Malatynska, E.; Knapp, R.J.; Roeske, W.R.; Yamamura, H.I. 1996: delta-Opioid receptor: the third extracellular loop determines naltrindole selectivity. European Journal of Pharmacology 300(1-2): R1-R2

Lishner, M.; Ravid, M.; Shapira, J.; Radnay, J.; Amiel, A.; Leytin, V.; Shapiro, C.; Klein, A. 1994: Delta-T-lymphocytosis in a patient with thymoma. Cancer 74(11): 2924-2929

Ohno, M.; Kojima, S.; Shirakawa, Y.; Eguchi, S. 1996: Delta-Valerolactam derivative of C-60 from hetero Diels-Alder reaction with 1,3-bis(tert-butyldimethylsilyloxy)-2-aza-1,3-butadiene. Tetrahedron Letters 37(51): 9211-9214

D.B.nis, A.F.; Rossetti, M.V.; Batlle, A.M.D.l C. 1992: Delta-aminolevulinate dehydratase from free-living Rhizobium. International Journal of Biochemistry 24(11): 1841-1847

Ambrogi, C.; Cardini, G.; Baldi, S.B.; Cini, C.C.; Buzzigoli, G.; Quinones-Galvan, A.; Ferrannini, E. 1996: Delta-aminolevulinic acid dehydratase and zinc protoporphyrin in very low lead-exposed pets: a community study. Veterinary and Human Toxicology 38(5): 336-339

Bergdahl, I.A.; Gerhardsson, L.; Schütz, A.; Desnick, R.J.; Wetmur, J.G.; Skerfving, S. 1997: Delta-aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans. Archives of Environmental Health 52(2): 91-96

Kaushik, C.P.; Gupta, S.; Kumar, S.; Kaushik, A. 1995: Delta-aminolevulinic acid of children as an index of lead exposure. Indian Journal of Environmental Health 37(2): 115-119

Döring, F.; Walter, J.; Will, J.; Föcking, M.; Boll, M.; Amasheh, S.; Clauss, W.; Daniel, H. 1998: Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. Journal of Clinical Investigation 101(12): 2761-2767

Eleouet, S.; Carre, J.; Vonarx, V.; Heyman, D.; Lajat, Y.; Patrice, T. 1997: Delta-aminolevulinic acid-induced fluorescence in normal human lymphocytes. Journal of Photochemistry and Photobiology B Biology 41(1-2): 22-29,.

Chakrabarti, P.; Orihuela, E.; Egger, N.; Neal, D.E.; Gangula, R.; Adesokun, A.; Motamedi, M. 1998: Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines: implication for photodynamic therapy of prostate cancer. Prostate 36(4): 211-218

Le Moine, C.; Kieffer, B.; Gaveriaux-Ruff, C.; Befort, K.; Bloch, B. 1994: Delta-opioid receptor gene expression in the mouse forebrain: Localization in cholinergic neurons of the striatum. Neuroscience 62(3): 635-640

Brown, D.R.; Poonyachoti, S.; Osinski, M.A.; Kowalski, T.R.; Pampusch, M.S.; Elde, R.P.; Murtaugh, M.P. 1998: Delta-opioid receptor mRNA expression and immunohistochemical localization in porcine Ileum. Digestive Diseases and Sciences 43(7): 1402-1410

Zachariou, V.; Goldstein, B.D. 1996: Delta-Opioid receptor modulation of the release of substance P-like immunoreactivity in the dorsal horn of the rat following mechanical or thermal noxious stimulation. Brain Research 736(1-2): 305-314

Thorlin, T.; Eriksson, P.S.; Persson, P.A.; Aberg, N.D.; Hansson, E.; Rönnbäck, L. 1998: Delta-opioid receptors on astroglial cells in primary culture: Mobilization of intracellular free calcium via a pertussis sensitive G protein. Neuropharmacology 37(3): 299-311

Hernández, L.L.; Singha, A.K. 1998: Delta-opioid stimulation by BW373U86 promotes autonomic reactivity to stressors and alters attention-related cardiac responses in rabbits. Experimental and Clinical Psychopharmacology 6(1): 10-21

Sánchez-Blázquez, P.; Garzón, J. 1993: Delta-opioid supraspinal antinociception in mice is mediated by Gi3 transducer proteins. Life Sciences 53(7): Pl129-Pl134

Smart, D.; Lambert, D.G. 1996: Delta-Opioids stimulate inositol 1,4,5-trisphosphate formation, and so mobilize Ca2+ from intracellular stores, in undifferentiated NG108-15 cells. Journal of Neurochemistry 66(4): 1462-1467

Shandra, A.A.; Godlevskii, L.S.; Mikhaleva, I.I.; Lobenko, A.A.; Panenko, A.V.; Mazarati, A.M. 1993: Delta-sleep-inducing peptide and its role in the regulation of the epileptic activity. Fiziologicheskii Zhurnal Imeni I M Sechenova 79(2): 16-30

Späth-Schwalbe, E.; Schäfer, A.; Uthgenannt, D.; Born, J.; Fehm, H.L. 1995: Delta-sleep-inducing peptide does not affect CRH and meal-induced ACTH and cortisol secretion. Psychoneuroendocrinology 20(3): 231-237

Gray, R.A.; Vander Velde, D.G.; Burke, C.J.; Manning, M.C.; Middaugh, C.R.; Borchardt, R.T. 1994: Delta-sleep-inducing peptide: Solution conformational studies of a membrane-permeable peptide. Biochemistry 33(6): 1323-1331

Peck, V.M.; Gerner, E.W.; Cress, A.E. 1992: Delta-type DNA polymerase characterized from Drosophila melanogaster embryos. Nucleic Acids Research 20(21): 5779-5784

Clements, D.J.; Matveyeva, M.; McCoy, K.L. 1998: Delta9-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression. International Journal of Immunopharmacology 20(8): 415-428

Darbyshire, J.H.; Aboulker, J.P. 1996: Delta: A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet (North American Edition) 348(9023): 283-291

Casshyap, S.M.; Aslam, M. 1992: Deltaic and shoreline sedimentation in Saurashtra Basin, western India: An example of infilling in an early Cretaceous failed rift. Journal of Sedimentary Petrology 62(6): 972-991

Van Bortel, W.; Delacollette, C.; Barutwanayo, M.; Coosemans, M. 1996: Deltamethrin-impregnated bednets as an operational tool for malaria control in a hyper-endemic region of Burundi: impact on vector population and malaria morbidity. Tropical Medicine and International Health: Tm and Ih 1(6): 824-835

Enan, E.; Pinkerton, K.E.; Peake, J.; Matsumura, F. 1996: Deltamethrin-induced thymus atrophy in male Balb/c mice. Biochemical Pharmacology 51(4): 447-454

Bowman, T., E.; Orsi, J., J. 1992: Deltamysis holmquistae, new genus new species, of Mysidacea from the Sacramento-San Joaquin estuary of California (Mysidae: Mysinae: Heteromysini). Proceedings of the Biological Society of Washington 105(4): 733-742

Matsuno, K.; Diederich, R.J.; Go, M.J.; Blaumueller, C.M.; Artavanis-Tsakonas, S. 1995: Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats. Development 121(8): 2633-2644

Miller, C.D.; Shelton, W.R.; Barrett, G.R.; Savoie, F.H.; Dukes, A.D. 1995: Deltoid and syndesmosis ligament injury of the ankle without fracture. American Journal of Sports Medicine 23(6): 746-750

Kovalenko, S.A.; Kopsidas, G.; Kelso, J.M.; Linnane, A.W. 1997: Deltoid human muscle mtDNA is extensively rearranged in old age subjects. Biochemical and Biophysical Research Communications 232(1): 147-152

Uddhammar, A.; Rantapää Dahlqvist, S.; Hedberg, B.; Thornell, L.E. 1998: Deltoid muscle in patients with polymyalgia rheumatica. Journal of Rheumatology 25(7): 1344-1351

Kimura, Y.O. 1992: Deltopectal flap for one-stage reconstruction of pharyngocutaneous fistula following total laryngectomy. Jibi Inkoka Tokeibu Geka 64(10): 763-766

Portnoy, W.M.; Arena, S. 1994: Deltopectoral island flap. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 111(1): 63-69

Fiori, A.; Cardelli, P.; Negri, L.; Savi, M.R.; Strom, R.; Erspamer, V. 1997: Deltorphin transport across the blood-brain barrier. Proceedings of the National Academy of Sciences of the United States of America 94(17): 9469-9474

Sigmund, D. 1998: Delusion and intuition. Nervenarzt 69(5): 390-400

Hrdlicka, M. 1998: Delusion of maternity. Psychopathology 31(5): 270-273

Adityanjee, A.M. 1995: Delusion of pregnancy in males: a case report and literature review. Psychopathology 28(6): 307-311

Jones, E.; Watson, J.P. 1997: Delusion, the overvalued idea and religious beliefs: a comparative analysis of their characteristics. British Journal of Psychiatry: the Journal of Mental Science 170: 381-386

Jørgensen, P.; Jensen, J. 1994: Delusional beliefs in first admitters. A clinical description. Psychopathology 27(1-2): 100-112

Baldwin, R.C. 1995: Delusional depression in elderly patients: Characteristics and relationship to age at onset. International Journal of Geriatric Psychiatry 10(11): 981-985

Campana, A.; Gambini, O.; Scarone, S. 1998: Delusional disorder and eye tracking dysfunction: Preliminary evidence of biological and clinical heterogeneity. Schizophrenia Research 30(1): 51-58

Marino, C.; Nobile, M.; Bellodi, L.; Smeraldi, E. 1993: Delusional disorder and mood disorder: can they coexist?. Psychopathology 26(2): 53-61

Kaplan, Z.; Lichtenberg, P. 1995: Delusional disorder, somatic subtype, treated with fluvoxamine. European Journal of Psychiatry 9(4): 238-241

Manschreck, T.C. 1996: Delusional disorder: the recognition and management of paranoia. Journal of Clinical Psychiatry 57(Suppl): 32-38

Munro, A. 1994: Delusional disorders are a naturally occurring 'experimental psychosis'. Psychopathology 27(3-5): 247-250

Tsai, S.J.; Hwang, J.P.; Yang, C.H.; Liu, K.M. 1997: Delusional jealousy in dementia. Journal of Clinical Psychiatry 58(11): 492-494

Brieger, P.; Schulte-Mattler, W.; Zierz, S. 1996: Delusion of mercury poisoning in multiple sclerosis. Der Nervenarzt 67(9): 785-788

Silva, J.A.; Leong, G.B.; Weinstock, R.; Wine, D.B. 1993: Delusional misidentification and dangerousness: a neurobiologic hypothesis. Journal of Forensic Sciences 38(4): 904-913

Förstl, H.; Besthorn, C.; Burns, A.; Geiger-Kabisch, C.; Levy, R.; Sattel, A. 1994: Delusional misidentification in Alzheimer's disease: a summary of clinical and biological aspects. Psychopathology 27(3-5): 194-199

Pourgourides, C.; Oyebode, F. 1997: Delusional misidentification in autobiographical narrative. Psychopathology 30(1): 20-24

Silva, J.A.; Leong, G.B.; Ferrari, M.M. 1995: Delusional misidentification of health care professionals. Psychiatric Quarterly 66(1): 51-61

Ellis, H.D.; Luauté, J.P.; Retterstøl, N. 1994: Delusional misidentification syndromes. Psychopathology 27(3-5): 117-120

Oyebode, F.; Sargeant, R. 1996: Delusional misidentification syndromes: a descriptive study. Psychopathology 29(4): 209-214

Paillère-Martinot, M.L.; Dao-Castellana, M.H.; Masure, M.C.; Pillon, B.; Martinot, J.L. 1994: Delusional misidentification: a clinical, neuropsychological and brain imaging case study. Psychopathology 27(3-5): 200-210

de Pauw, K.W. 1994: Delusional misidentification: a plea for an agreed terminology and classification. Psychopathology 27(3-5): 123-129

Fleminger, S. 1994: Delusional misidentification: an exemplary symptom illustrating an interaction between organic brain disease and psychological processes. Psychopathology 27(3-5): 161-167

McEvedy, C.J.; Hendry, J.; Barnes, T.R. 1996: Delusional misidentification: the illusion of Fregoli and a dog. Psychopathology 29(4): 215-217

Marková, I.S.; Berrios, G.E. 1994: Delusional misidentifications: facts and fancies. Psychopathology 27(3-5): 136-143

Gomez-Feria-Prieto, I. 1996: Delusional of parasitosis: Review and study of two cases. Psiquis 17(10): 47-51

Querol-Nasarre, A.; Querol-Nasarre, I.; Quetglas-Ferriol, B.; Fernandez-Rodriguez, L.J. 1997: Delusional parasitosis (Ekbom's Syndrome): Review and exposition of a clinical case. Psiquis 18(4): 56-59

Driscoll, M.S.; Rothe, M.J.; Grant-Kels, J.M.; Hale, M.S. 1993: Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach. Journal of the American Academy of Dermatology 29(6): 1023-1033

Winsten, M. 1997: Delusional parasitosis: a practical guide for the family practitioner in evaluation and treatment strategies. Journal of the American Osteopathic Association 97(2): 95-99

Shiwach, R.S.; Dudley, A.F. 1997: Delusional pregnancy with polydipsia: A case report. Journal of Psychosomatic Research 42(5): 477-480

Binetti, G.; Padovani, A.; Magni, E.; Bianchetti, A.; Scuratti, A.; Lenzi, G.L.; Trabucchi, M. 1995: Delusions and dementia: Clinical and CT correlates. Acta Neurologica Scandinavica 91(4): 271-275

Haupt, M.; Romero, B.; Kurz, A. 1996: Delusions and hallucinations in Alzheimer's disease: Results from a two-year longitudinal study. International Journal of Geriatric Psychiatry 11(11): 965-972

Binetti, G.; Bianchetti, A.; Padovani, A.; Lenzi, G.; De Leo, D.; Trabucchi, M. 1993: Delusions in Alzheimer's disease and multi-infarct dementia. Acta Neurologica Scandinavica 88(1): 5-9

Wilkins, R. 1993: Delusions in children and teenagers admitted to Bethlem Royal Hospital in the 19th century. British Journal of Psychiatry: the Journal of Mental Science 162: 487-492

Gladis, M.M.; Levinson, D.F.; Mowry, B.J. 1994: Delusions in schizophrenia spectrum disorders: diagnostic issues. Schizophrenia Bulletin 20(4): 747-754

Maeda, K.; Yamamoto, Y.; Yasuda, M.; Ishii, K. 1998: Delusions of oral parasitosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 22(1): 243-248

Zomer, S.F.; De Wit, R.F.; Van Bronswijk, J.E.; Nabarro, G.; Van Vloten, W.A. 1998: Delusions of parasitosis. A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. British Journal of Dermatology 138(6): 1030-1032

Michael, A.; Joseph, A.; Pallen, A. 1994: Delusions of pregnancy. British Journal of Psychiatry: the Journal of Mental Science 164(2): 244-246

Curran, J.S.M.; Pugh, R.E. 1995: Delusions of pregnancy and delivery in elderly women. International Journal of Geriatric Psychiatry 10(12): 1075-1076

Harland, R.F.; Warner, N.J. 1997: Delusions of pregnancy in the elderly. International Journal of Geriatric Psychiatry 12(1): 115-117

Silva, J.A.; Leong, G.B. 1994: Delusions of psychological change of the self. Psychopathology 27(6): 285-290

Lange, R.; Houran, J. 1998: Delusions of the paranormal: a haunting question of perception. Journal of Nervous and Mental Disease 186(10): 637-645

Hwang, J.P.; Yang, C.H.; Tsai, S.J.; Liu, K.M. 1997: Delusions of theft in dementia of the Alzheimer type: a preliminary report. Alzheimer Disease and Associated Disorders 11(2): 110-112

Silva, J.A.; Leong, G.B.; Weinstock, R. 1993: Delusions of transformation of the self. Psychopathology 26(3-4): 181-188

Jovic, Nikola-Ivan 1997: Delusions, misidentifications and hallucinations in Alzheimer's disease. Croatian Medical Journal 38(3): 228-232

Vickery, D.M.; Lynch, W.D. 1995: Demand management: enabling patients to use medical care appropriately. Journal of Occupational and Environmental Medicine 37(5): 551-557

De Kanter, R.J.; Käyser, A.F.; Battistuzzi, P.G.; Truin, G.J.; Van 't Hof, M.A. 1992: Demand and need for treatment of craniomandibular dysfunction in the Dutch adult population. Journal of Dental Research 71(9): 1607-1612

Foster, T.M.; Temple, W.; Cameron, B.; Poling, A. 1997: Demand curves for food in hens: Similarity under fixed-ratio and progressive-ratio schedules. Behavioural Processes 39(2): 177-185

Sánchez-Vázquez, F.J.; Madrid, J.A.; Zamora, S.; Iigo, M.; Tabata, M. 1996: Demand feeding and locomotor circadian rhythms in the goldfish, Carassius auratus: dual and independent phasing. Physiology and Behavior 60(2): 665-674

Zambalde, A.L.; Nogueira, J.L. 1994: Demand for computer science in the agricultural enterprises in Minas Gerais State. Ciencia e Pratica 18(2): 133-137

Langley, J.M.; Hanakowski, M.; Bortolussi, R. 1994: Demand for isolation beds in a pediatric hospital. American Journal of Infection Control 22(4): 207-211

Cooper, J.J.; Appleby, M.C. 1996: Demand for nest boxes in laying hens. Behavioural Processes 36(2): 171-182

Taylor, S.D. 1994: Demand for predictive genetic testing for Huntington's disease in Australia, 1987 to 1993. Medical Journal of Australia 161(6): 351 354-5

Sheldrick, J.H.; Vernon, S.A.; Wilson, A.; Read, S.J. 1992: Demand incidence and episode rates of ophthalmic disease in a defined urban population. BMJ 305(6859): 933-936

Savageau, M.A. 1998: Demand theory of gene regulation. II. Quantitative application to the lactose and maltose operons of Escherichia coli. Genetics 149(4): 1677-1691

Murray, J.M.; Seaberg, D.C.; Menegazzi, J.J. 1996: Demand valve ventilation in a swine pneumothorax model. American Journal of Emergency Medicine 14(1): 13-15

Lappartient, A..G..; Touraine, B.. 1996: Demand-Driven Control of Root ATP Sulfurylase Activity and SO42- Uptake in Intact Canola (The Role of Phloem-Translocated Glutathione). Plant Physiology 111(1): 147-157

Chiang, A.A.; Steinfeld, A.; Gropper, C.; MacIntyre, N. 1994: Demand-flow airway pressure release ventilation as a partial ventilatory support mode: comparison with synchronized intermittent mandatory ventilation and pressure support ventilation. Critical Care Medicine 22(9): 1431-1437

Cook, L.L.; Persinger, M.A. 1996: Demands during maze. learning in limbic epileptic rats: selective damage in the thalamus?. Perceptual and Motor Skills 83(1): 323-329

Rovira-Carballido, J.; Rovira-Viyella, A.; Moreno, I.J.ime 1994: Demands for quality in the food industries: The meat industry. Alimentaria 31(249): 22-26

Pfandl, S.; Wetzel, R.; Puhl, W. 1993: Demands on and reality of antirheumatoid drug therapy: A retrospective study of 100 rheumatoid arthritis patients. Aktuelle Rheumatologie 18(4): 127-131

Naiyanetr, P. 1992: Demanietta sirikit, new species, a new freshwater crab from Thailand (Decapoda, Brachyura, Potamidae). Crustaceana 62(2): 113-120

Grant, C.C.; Biggs, H.C.; Meissner, H.H. 1996: Demarcation of potentially mineral-deficient areas in central and northern Namibia by means of natural classification systems. Onderstepoort Journal of Veterinary Research 63(2): 109-120

Lueger, J. 1996: Demarcation of protection zones for the wells of water supply plants to reduce nitrate concentrations. Oesterreichische Wasser- und Abfallwirtschaft 48(3-4): 93-101

Sterflinger, K.; Krumbein, W.E. 1997: Dematiaceous fungi as a major agent for biopitting on Mediterranean marbles and limestones. Geomicrobiology Journal 14(3): 219-230

Mckenzie, E.H.C.; Kuthubutheen, A.J. 1993: Dematiaceous hyphomycetes on Freycinetia (Pandanaceae): 4. Cryptophiale. Mycotaxon 47: 87-92

Mckenzie, E.H.C. 1995: Dematiaceous hyphomycetes on Pandanaceae: 5. Sporidesmium sensu lato. Mycotaxon 56: 9-29

Pappagianis, D.; Ajello, L. 1994: Dematiaceous--a mycologic misnomer?. Journal of Medical and Veterinary Mycology: Bi-Monthly Publication of the International Society for Human and Animal Mycology 32(4): 319-321

Rosenvinge, H.; Jones, D.; Judge, E.; Martin, A. 1998: Demented and chronic depressed patients attending a day hospital: Stress experienced by carers. International Journal of Geriatric Psychiatry 13(1): 8-11

Power, C.; McArthur, J.C.; Johnson, R.T.; Griffin, D.E.; Glass, J.D.; Perryman, S.; Chesebro, B. 1994: Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. Journal of Virology 68(7): 4643-4649

Censori, B.; Manara, O.; Agostinis, C.; Camerlingo, M.; Casto, L.; Galavotti, B.; Partziguian, T.; Servalli, M.C.; Cesana, B.; Belloni, G.; Mamoli, A. 1996: Dementia after first stroke. Stroke 27(7): 1205-1210

Moroney, J.T.; Bagiella, E.; Tatemichi, T.K.; Paik, M.C.; Stern, Y.; Desmond, D.W. 1997: Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 48(5): 1317-1325

Tatemichi, T.K.; Paik, M.; Bagiella, E.; Desmond, D.W.; Pirro, M.; Hanzawa, L.K. 1994: Dementia after stroke is a predictor of long-term survival. Stroke 25(10): 1915-1919

Ganguli, M.; Cauley, J.A.; DeKosky, S.T.; Kamboh, M.I. 1995: Dementia among elderly apolipoprotein e type 4/4 homozygotes: a prospective study. Genetic Epidemiology 12(3): 309-311